Metabolic and inflammatory factors in upper extremity soft-tissue disorders by Rechardt, Martti
Department of Public Health 
Occupational Health 
Faculty of Medicine 
Doctoral Programme in Clinical Research 
University of Helsinki 
Finland 
 
 
 
 
 
 
METABOLIC AND INFLAMMATORY FACTORS 
IN UPPER EXTREMITYS SOFT-TISSUE 
DISORDERS 
 
 
 
 
Martti Rechardt 
 
 
 
 
 
 
 
 
 
 
 
ACADEMIC DISSERTATION 
 
To be presented, with the permission of the Faculty of Medicine  
of the University of Helsinki, for public examination in Auditorium XII, 
University main building, on 5 May 2017, at 12 noon. 
 
Helsinki 2017 
 
 
 Supervisors 
 
Professor Eira Viikari-Juntura, MD, PhD 
Finnish Institute of Occupational Health  
Helsinki, Finland 
 
Docent Rahman Shiri, MD, PhD, MPH 
Finnish Institute of Occupational Health 
Helsinki, Finland 
 
 
Reviewers 
 
Professor Pekka Mäntyselkä, MD, PhD 
Institute of Public health and Clinical Nutrition 
University of Eastern Finland  
Kuopio, Finland  
 
Associative professor Johannes Gjerstad, PhD 
Department of Biosciences 
University of Oslo 
Oslo, Norway  
 
 
Opponent 
 
Docent Katri Laimi, MD, PhD 
Department of Physical and Rehabilitation Medicine 
Turku University Hospital  
Turku, Finland 
 
 
 
 
Dissertationes Scholae Doctoralis Ad Sanitatem Investigandam Universitatis 
Helsinkiensis No. 22/2017 
 
Cover layout: Anita Tienhaara 
 
ISBN 978-951-51-3007-5 (paperback) 
ISBN 978-951-51-3018-1 (PDF) 
 
ISSN 2342-3161 (print) 
ISSN 2342-317X (online) 
 
Unigrafia 2017 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
But where can wisdom be found? 
And where is the place of understanding? 
Job 28:12 
 
SUMMARY 
Upper extremity soft-tissue disorders (UESTDs) are common painful conditions 
relating to tendons and their adjacent structures. The etiology of UESTDs, 
particularly the role of metabolic and inflammatory factors, is unknown. Some 
studies have found associations between obesity and diabetes with UESTDs. To date, 
few studies have assessed the role of cytokines in UESTDs and virtually nothing is 
known about the role of adipokines in these disorders. Animal experiments as well as 
studies conducted with human tissue samples have found evidence of inflammation 
in tendons, suggesting that pro-inflammatory cytokines play a role in UESTDs. The 
expressions of pro-inflammatory cytokines and adipokines in serum are altered in 
obesity, however it is unclear whether these compounds contribute to the symptoms 
experienced by UESTD patients.   
   The overall aim of this study was to explore the role of metabolic and inflammatory 
factors in shoulder pain and UESTDs. This study utilized the Health 2000 Survey, a 
health examination of a representative sample of the Finnish general population 
conducted by the National Institute of Health and Welfare (N = 6354).  In addition, a 
sample of actively working patients with incipient UESTDs (N = 163) and a healthy 
control group (N = 42) were examined in the Finnish Institute of Occupational 
Health. 
   In a representative sample of the general population, the prevalence of shoulder 
joint pain in the past month was 16% and that of possible or probable chronic rotator 
cuff tendinitis was 3%. Every third patient with incipient UESTDs, reported full or 
substantial recovery within three months. Body mass index, waist circumference and 
type 2 diabetes were associated with shoulder joint pain, whereas waist 
circumference was associated with chronic rotator cuff tendinitis. Moreover, waist 
circumference, low levels of HDL cholesterol, high levels of triglycerides and high 
levels of an adipokine, visfatin, were associated with the intensity of upper extremity 
pain in patients with incipient UESTDs. Serum levels of soluble interleukin 1 receptor 
2 and soluble ST2 receptor were higher and those of interleukin 18 lower in patients 
with incipient UESTDs compared with the healthy controls. Furthermore, high levels 
of two adipokines, resistin and visfatin, predicted a higher recovery rate from 
UESTDs.  
   The study findings suggest that obesity and diabetes are associated with upper 
extremity pain and chronic rotator cuff tendinitis. The underlying mechanisms are 
largely unknown, however the increased expression of pro-inflammatory cytokines in 
obesity may modify pain sensitivity and promote inflammation in tendon and its 
adjacent structures. In diabetes, the precipitation of advanced glycation end products 
in tendons is thought to increase the tissue’s susceptibility to tendon disorders.  
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   Furthermore, the findings point towards an independent role of interleukin 1 family 
biomarkers in UESTDs. Therefore, incipient UESTDs may promote inflammatory 
activity, potentially altering serum biomarker levels. Finally, adipokines are 
recognized to exert a role in inflammation; the findings of this study suggest that they 
may play a role as modifiers of upper extremity pain intensity and also in the 
recovery from UESTDs.    
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YHTEENVETO 
Yläraajan jänteisiin ja niitä ympäröiviin kudoksiin paikantuvat sairaudet eli yläraajan 
pehmytkudossairaudet ovat yleinen yläraajakivun aiheuttaja väestössä. Näiden 
sairauksien syitä ja syntymekanismeja ei tunneta tarkkaan. Eräissä tutkimuksissa 
lihavuus ja diabetes ovat olleet yhteydessä yläraajan jännesairauksien esiintyvyyteen. 
Tulehdusvälittäjäaineiden eli sytokiinien merkitystä yläraajan 
pehmytkudossairauksissa on tutkittu vähän ja mm. rasvakudoksen erittämien 
adipokiinien merkitystä niissä ei ole tutkittu lainkaan. Koe-eläimiltä ja potilailta 
saatujen kudosnäytteiden jännerakenteista on löydetty merkkejä tulehduksesta, 
minkä perusteella sytokiinien on ajateltu liittyvän yläraajan pehmytkudossairauksien 
kehittymiseen. Lihavuus aiheuttaa sekä sytokiinien että adipokiinien pitoisuuksien 
muutoksia veressä. Näiden veressä esiintyvien merkkiaineiden yhteys yläraajan 
pehmytkudossairauksiin on kuitenkin vielä selvittämättä. 
   Tämän tutkimuksen tavoitteena oli tarkastella aineenvaihdunta- ja 
tulehdustekijöiden yhteyttä olkapääkipuun ja yläraajan pehmytkudossairauksiin. 
Olkapään sairauksia selvittävään tutkimukseen valittiin suomalaista väestöä 
edustavaan Terveyden ja hyvinvoinnin laitoksen Terveys 2000 -tutkimukseen 
osallistuneet työikäiset henkilöt (N=6354). Yläraajan pehmytkudossairauksia 
selvitettiin Työterveyslaitoksen yläraajaprojektissa työterveyshuoltoon yläraajakivun 
vuoksi hakeutuneilla työntekijöillä (N=163). Heille valittiin yläraajasairauksien 
suhteen terveistä henkilöistä koostuva kontrolliryhmä (N=42). Terveys 2000 -
tutkimukseen osallistuneet ja työterveyshuoltoon hakeutuneet henkilöt tutkittiin 
kliinisesti. Kaikilta tutkittavilta mitattiin pituus, paino ja vyötärönympärys sekä 
otettiin verinäyte aineenvaihdunta- ja tulehdustekijöiden määrittämistä varten.  
   Olkapääkipua oli viimeksi kuluneiden 30 päivän aikana ollut 16 % :lla suomalaisista 
työikäisistä. Krooninen kiertäjäkalvosimen oireyhtymä todettiin kliinisessä 
tutkimuksessa 3 %:lla. Työterveyshuollon potilasaineistossa merkittävimmät 
diagnoosiryhmät olivat kiertäjäkalvosimen tendinopatia ja kyynärpään 
sivunastatulehdus, joita kumpaakin oli noin kolmannes tapauksista. Viidenneksellä 
oli kipua ilman spesifistä diagnoosia. Kolmannes potilaista toipui joko olennaisesti 
tai kokonaan kolmessa kuukaudessa.  
   Painoindeksi, vyötärönympärys ja tyypin 2 diabetes olivat väestöaineistossa 
yhteydessä olkapääkivun esiintyvyyteen. Vyötärönympärys oli yhteydessä myös 
kroonisen kiertäjäkalvosinoireyhtymän esiintyvyyteen. Vyötärönympärys, matala 
HDL-kolesteroli, kohonneet triglyseridit ja adipokiini visfatiinin korkea pitoisuus 
seerumissa olivat yhteydessä yläraajakipuun yläraajapotilailla. Seerumin liukoisen 
interleukiini 1 -reseptori 2:n sekä ST2-reseptorin pitoisuudet olivat merkittävästi 
korkeampia yläraajapotilailla verrattuna terveisiin kontrollihenkilöihin. Lisäksi 
adipokiinien resistiini ja visfatiini korkeat pitoisuudet olivat yhteydessä 
yläraajapotilaiden parempaa toipumisennusteeseen.  
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   Tutkimustulosten perusteella lihavuudella ja diabeteksella on yhteys olkapääkipuun 
ja krooniseen kiertäjäkalvosimen oireyhtymään. Yhteyden taustalla olevia 
mekanismeja ei tunneta hyvin. Lihavuuteen liittyen veressä kiertävät sytokiinit voivat 
herkistää kivulle ja ylläpitää tulehdusta jännerakenteissa. Diabeetikoilla 
glykosylaation seurauksena jänteisiin kertyvien aineenvaihduntatuotteiden ajatellaan 
aiheuttavan jännetulehduksia.  
   Potilasaineistolla interleukiini 1 -perheen merkkiaineilla oli riippumaton yhteys 
yläraajan pehmytkudossairauksiin. Löydöksen perusteella yläraajan 
pehmytkudossairauksiin voisi alkuvaiheessa liittyä tulehdusta, joka muuttaa 
seerumin merkkiainepitoisuuksia. Myös adipokiinien tiedetään liittyvän 
tulehdukseen. Tutkimuksen havainnot viittaavat siihen, että adipokiineilla saattaa 
olla vaikutusta yläraajakipuun sekä yläraajan pehmytkudossairauksista toipumiseen.  
CONTENTS 
SUMMARY ............................................................................................................... 4?
YHTEENVETO ......................................................................................................... 6?
ABBREVIATIONS ................................................................................................... 10?
PUBLICATIONS ...................................................................................................... 11?
1? INTRODUCTION ............................................................................................... 12?
2? REVIEW OF THE LITERATURE ..................................................................... 14?
2.1? Definition of upper extremity disorders ..................................................... 14?
2.2? Prevalence and incidence of upper extremity musculoskeletal disorders 15?
2.2.1? Prevalence ............................................................................................ 15?
2.2.2? Incidence .............................................................................................. 16?
2.3? Risk factors for UESTDs ............................................................................. 17?
2.3.1? Biological factors .................................................................................. 17?
2.3.1.1? Sex .................................................................................................. 17?
2.3.1.2? Age ................................................................................................. 19?
2.3.2? Physical and psychosocial factors at work ......................................... 20?
2.3.2.1? Physical factors at work ................................................................ 20?
2.3.2.2? Psychosocial factors at work ......................................................... 21?
2.3.3? Lifestyle and metabolic factors in UESTDs ........................................ 22?
2.3.3.1? Obesity .......................................................................................... 22?
2.3.3.2? Diabetes ........................................................................................ 23?
2.3.3.3? Dyslipidemia ................................................................................. 25?
2.3.3.4? Leisure time physical activity ....................................................... 25?
2.3.3.5? Smoking ........................................................................................ 26?
2.4? Adipokines .................................................................................................. 27?
2.4.1? Leptin .................................................................................................... 27?
2.4.2? Adiponectin ......................................................................................... 28?
2.4.3? Visfatin ................................................................................................ 28?
2.4.4? Resistin ............................................................................................... 28?
2.5? Inflammatory markers in UESTDs ........................................................... 29?
2.5.1? Mechanisms of tendon inflammation ................................................. 29?
2.5.2? Interleukin 1 family ............................................................................. 30?
2.5.2.1? General concepts of the interleukin 1 family ............................... 30?
2.5.2.2? IL-1 family and UESTDs ............................................................... 31?
2.5.3? Interleukin 6 (IL-6) ............................................................................. 32?
2.5.4? Interleukin 8 (IL-8) ............................................................................ 32?
2.5.5? Tumor necrosis factor alpha (TNFα) .................................................. 33?
2.5.6? Transforming growth factor beta (TGFβ) .......................................... 33?
2.5.7? C-reactive protein (CRP) ..................................................................... 34?
2.6? Summary of existing information and gaps in our knowledge ................. 35?
3? AIMS OF THE STUDY ..................................................................................... 36?
4? METHODS AND MATERIALS ......................................................................... 37?
4.1? Study population ......................................................................................... 37?
4.1.1? Health 2000 Survey .............................................................................. 37?
8 
 9
4.1.2? Upper extremity project ....................................................................... 37?
4.1.2.1? Patients ........................................................................................... 37?
4.1.2.2? Controls ........................................................................................ 38?
4.2? Outcomes ................................................................................................... 38?
4.2.1? Health 2000 Survey ............................................................................ 38?
4.2.2? Upper extremity project ..................................................................... 39?
4.3? Independent variables ............................................................................... 39?
4.3.1? Health 2000 Survey ............................................................................ 39?
4.3.2? Upper extremity project ..................................................................... 40?
4.4? Statistical analyses ..................................................................................... 42?
4.4.1? Health 2000 Survey ............................................................................ 42?
4.4.2? Upper extremity project ..................................................................... 42?
4.5? Ethical statement ....................................................................................... 43?
5? RESULTS .......................................................................................................... 44?
5.1? Health 2000 Survey (Study I) .................................................................... 44?
5.1.1? Shoulder joint pain (Study I) ............................................................... 45?
5.1.2? Chronic rotator cuff tendinitis (Study I) ............................................. 46?
5.2? Upper extremity project (Studies II, III and IV) ....................................... 48?
5.2.1? Upper extremity pain (Study II) ......................................................... 48?
5.2.2? Upper extremity soft tissue disorders (Study III) .............................. 49?
5.2.3? Recovery from upper extremity soft tissue disorders (Study IV) ...... 49?
6? DISCUSSION .................................................................................................... 50?
6.1? Main findings ............................................................................................. 50?
6.2? Prevalence and recovery rate .................................................................... 50?
6.3? Overweight and obesity .............................................................................. 51?
6.4? Diabetes ...................................................................................................... 52?
6.5? Dyslipidemia ............................................................................................... 52?
6.6? Inflammatory biomarkers .......................................................................... 53?
6.7? Adipokines ................................................................................................. 54?
6.8? Study strengths ........................................................................................... 55?
6.9? Study limitations ....................................................................................... 56?
6.10? Conclusions ............................................................................................... 57?
ACKNOWLEDGEMENTS ...................................................................................... 59?
REFERENCES ......................................................................................................... 61?
ABBREVIATIONS 
 
AGE Advanced glycation end product 
BMI body mass index 
CI confidence interval 
COX2 cyclooxygenase 2 
CRP C-reactive protein 
GEE generalized estimating equation 
HDL high density lipoprotein 
IL-1 interleukin 1 (6, 8, 18, 21, 33) 
IL1-Ra interleukin 1 receptor antagonist 
OR odds ratio 
PGE2 prostaglandin E2 
SD standard deviation 
sIL-1RII soluble interleukin 1 receptor 2 
TGFβ transforming growth factor beta 
Th2 T helper 2 
TNFα tumor necrosis factor alpha 
UESTD upper extremity soft tissue disorder 
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 1 INTRODUCTION 
Upper extremity soft-tissue disorders (UESTDs) are tendon-related painful 
conditions, distinguishable from nerve entrapments and osteoarthritis. They 
are prevalent, frequently associated with work disability and some of them 
may result in high healthcare costs (Silverstein, Viikari-Juntura et al. 2002, 
Huisstede, Bierma-Zeinstra et al. 2006, Lipscomb, Schoenfisch et al. 2015). 
Between 20% and 40% of the working population report that they have 
experienced upper limb pain during the preceding year (Huisstede, Bierma-
Zeinstra et al. 2006). In a national survey, one out of every ten Canadians 
aged 20 or older stated that they had suffered an upper extremity disorder 
during the preceding one year that was serious enough to limit their normal 
activities (IWH 2005). In Washington State between 1990 and 1998, upper 
extremity disorders resulted in $2.6 billion in direct costs and 20.5 million 
lost workdays (Silverstein, Viikari-Juntura et al. 2002). The European 
Agency for Safety and Health at Work has estimated that all costs due to 
work related neck and upper limb musculoskeletal disorders in the Nordic 
countries and the Netherlands ranged between 0.5% and 2% of the Gross 
National Product (Buckle and Devereux 1999). In  2013, 10% of all cases of 
occupational disease-related insurance compensation claims were 
attributable to UESTDs in Finland (FIOH 2015). According to the statistics of 
the Social Insurance Institution of Finland, soft-tissue disorders of the 
shoulder were the most commonly compensated group of UESTDs in 2014 
and constituted 4.4% of all compensated sickness absence days, averaging 44 
workdays per individual per year and totalling €41 million (SIIF 2014).  
 
   The etiology of UESTDs is only partly understood but there is one clear fact 
UESTDs are more likely to affect older individuals. Age is linearly associated 
with shoulder disorders, however the highest risk of epicondylitis is seen in 
individuals between 40 and 50 years (Shiri, Viikari-Juntura et al. 2006). All 
UESTDs are more prevalent in women compared to men (Treaster and Burr 
2004). Physical load factors increase the risk of all UESTDs (Leclerc, Landre 
et al. 2001, Roquelaure, Ha et al. 2009, van Rijn, Huisstede et al. 2010).  
   Obesity has been suggested to be associated with clinically defined UESTDs 
(Gaida, Ashe et al. 2009). Moreover, a few studies have found an association 
between obesity and non-specific shoulder pain (Evanoff, Sabbath et al. 
2014, Kim, Suh et al. 2015). There may be other metabolic factors, for 
example, diabetes has been suggested as a risk factor for rotator cuff 
tendinopathy and trigger finger tenosynovitis (Abate, Schiavone et al. 2013, 
Lin, Lin et al. 2015)  
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   The tendon and its adjacent structures show inflammation in UESTDs. 
Moreover, obesity increases the expression of adipokines and pro-
inflammatory cytokines. Accordingly, adipokines and cytokines might be 
components of an inflammatory process and possibly be considered as 
biomarkers for UESTDs. To date, there is only anecdotal information on the 
associations of adipokines and cytokines with UESTDs.  
   This study aims to explore the role of metabolic and inflammatory factors 
in clinically defined UESTDs and non-specific upper limb pain.  
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 2 REVIEW OF THE LITERATURE  
 2.1 DEFINITION OF UPPER EXTREMITY DISORDERS 
Upper extremity disorders include osteoarthritis in the joints, soft-tissue 
disorders of the tendon structures, peripheral nerve entrapment and 
different sequelae after accidental injuries. Upper extremity soft-tissue 
disorders (UESTDs) are a group of tendon related conditions emerging as a 
result of pathological alterations of the tendon matrix, peritendon, 
tenosynovium or bursas or tendon insertions producing pain in the site of 
the disorder, i.e. shoulder, elbow, forearm, wrist or hand. Identification of 
specific UESTDs such as rotator cuff tendinitis, lateral and medial 
epicondylitis as well as De Quervain’s tenosynovitis requires the fulfilment of 
predetermined criteria during the clinical examination (Sluiter, Rest et al. 
2001).  
   Rotator cuff tendinopathy: The structures involved in rotator cuff 
tendinopathy include the supraspinatus, the infraspinatus and subscapular 
tendons as well as the tendon of the long head of the biceps. Clinical signs of 
rotator cuff tendinopathy are pain upon resisted shoulder abduction, 
external or internal rotation, resisted elbow flexion and painful arc on active 
upper arm elevation (Sluiter, Rest et al. 2001).  
   Epicondylitis: Lateral and medial epicondylitis are characterized by activity 
related pain in the muscle-tendon junction or at the insertion of wrist 
extensor (lateral) or flexor (medial) muscles at the epicondyle (Sluiter, Rest 
et al. 2001). The clinical signs of epicondylitis include tenderness on 
palpation of the epicondyle and local pain on resisted wrist extension 
(lateral) or wrist flexion (medial).  
   Peritendinitis and tenosynovitis of the forearm and wrist region: 
Peritendinitis and tenosynovitis of the forearm and wrist region are 
characterized by recurrent pain on the movement of the wrist and finger 
extensors or flexors. The clinical findings include symptom provocation 
during resisted movement of the muscles and pain on palpation of the 
affected tendons. There may also be palpable crepitus and swelling of wrist 
or forearm dorsum (Sluiter, Rest et al. 2001). De Quervain’s disease is a 
stenosing tenosynovitis of the long abductor and short extensor tendons of 
the thumb. It is identified by the presence of pain over the radial side of the 
wrist and a positive Finkelstein’s test, or pain on resisted thumb extension or 
abduction.  
  15 
   Non-specific upper extremity pain: Non-specific upper extremity pain can 
be localized in the muscles, tendons or around the joints but the criteria of 
specific upper extremity disorders are not fulfilled.  
 
 2.2 PREVALENCE AND INCIDENCE OF UPPER 
EXTREMITY MUSCULOSKELETAL DISORDERS 
2.2.1 PREVALENCE 
Upper extremity pain 
In the general population, the prevalence of shoulder pain during the 
preceding month ranges from 11% to 30% (Luime, Koes et al. 2004, Miranda, 
Viikari-Juntura et al. 2005, Gill, Shanahan et al. 2013, Davatchi, Sandoughi 
et al. 2015), elbow pain from 7% to 14% (Urwin, Symmons et al. 1998, Sim, 
Lacey et al. 2006, Walker-Bone, Palmer et al. 2012, Hegmann, Thiese et al. 
2014, Davatchi, Sandoughi et al. 2015) and forearm pain from 8% to 15% 
(Macfarlane, Hunt et al. 2000, Sim, Lacey et al. 2006, Davatchi, Sandoughi 
et al. 2015). In the working population, the prevalence of shoulder pain 
during the preceding month ranges between 16% and 63% (Pandy 2013, 
Hegmann, Thiese et al. 2014, Nordander, Hansson et al. 2016), with elbow 
pain being less common, experienced by between 5% and 12% of the working 
population (Palmer, Cooper et al. 2001, Herquelot, Bodin et al. 2013, 
Hegmann, Thiese et al. 2014). Moreover, one out of every three members of 
the general working population reports that he/she has suffered some form 
of upper extremity pain during the preceding month (Roquelaure, Ha et al. 
2006, Sim, Lacey et al. 2006) and every fifth has experienced sufficient 
chronic pain to limit their daily activities (Gummesson, Atroshi et al. 2003). 
 
Upper extremity disorder 
In the general population, the prevalence of shoulder tendinopathy ranges 
between 2.5% and 7.4% (Walker-Bone, Palmer et al. 2004, Shiri, Varonen et 
al. 2007, Roquelaure, Ha et al. 2009, Davatchi, Sandoughi et al. 2015), 
lateral epicondylitis between 0.7% and 3.0% (Linaker, Walker-Bone et al. 
1999, Shiri, Varonen et al. 2007, Shiri and Viikari-Juntura 2011, Walker-
Bone, Palmer et al. 2012, Davatchi, Sandoughi et al. 2015), medial 
epicondylitis between 0.3% and 1.0% (Shiri, Varonen et al. 2007, Shiri and 
Viikari-Juntura 2011, Walker-Bone, Palmer et al. 2012, Davatchi, Sandoughi 
et al. 2015), de Quervain's disease between 0.2% and 1.2% (Walker-Bone, 
Palmer et al. 2004, Roquelaure, Ha et al. 2009, Davatchi, Sandoughi et al. 
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2015) and tenosynovitis of the hand or wrist between 0.8% and 1.7% 
(Walker-Bone, Palmer et al. 2004, Roquelaure, Ha et al. 2009). In the 
working population, the prevalence of shoulder tendinopathy ranges between 
6% and 30% (Bodin, Ha et al. 2012, Bugajska, Zolnierczyk-Zreda et al. 2013, 
Hegmann, Thiese et al. 2014, da Costa, Baptista et al. 2015, Nordander, 
Hansson et al. 2016, Stucchi, Battevi et al. 2016), lateral epicondylitis 
between 1% and 8% (Bugajska, Zolnierczyk-Zreda et al. 2013, Pullopdissakul, 
Ekpanyaskul et al. 2013, Gerr, Fethke et al. 2014, Hegmann, Thiese et al. 
2014, Meroni, Scelsi et al. 2014, Stucchi, Battevi et al. 2016), medial 
epicondylitis between 1% and 5%, and tendinopathy of the wrist and hand 
between 4% and 20% (Ono, Nakamura et al. 1998, Descatha, Leclerc et al. 
2003, Gold, d'Errico et al. 2009, Bugajska, Zolnierczyk-Zreda et al. 2013, 
Pullopdissakul, Ekpanyaskul et al. 2013, Gerr, Fethke et al. 2014, Stucchi, 
Battevi et al. 2016). 
 
2.2.2 INCIDENCE 
Upper extremity pain 
The annual incidence of shoulder pain ranges between 7% and 15% 
(Miranda, Viikari-Juntura et al. 2001, Bot, van der Waal et al. 2005, 
Ostergren, Hanson et al. 2005, Greving, Dorrestijn et al. 2012, Herin, Vézina 
et al. 2012, Lamy, Descatha et al. 2014) and arm or forearm pain between 4% 
and 21% (Macfarlane, Hunt et al. 2000, Bot, van der Waal et al. 2005, 
Palmer, Reading et al. 2008). In general practice populations, the annual 
incidence of the first consultation has been reported to be between 0.3% and 
1.1% for shoulder pain (Linaker, Walker-Bone et al. 1999, Bot, van der Waal 
et al. 2005, Greving, Dorrestijn et al. 2012, Tekavec, Jöud et al. 2012). 
 
Upper extremity disorders 
In the general population, the annual incidence of shoulder disorders ranges 
between 0.1% and 1.3% (Linaker, Walker-Bone et al. 1999, Bot, van der Waal 
et al. 2005, Shiue, Lu et al. 2008, Chung, Hung et al. 2013); for lateral 
epicondylitis, it is between 0.25% and 0.45% (Sanders, Maradit Kremers et 
al. 2015). In general practice populations, the annual incidence of 
consultations for a shoulder disorder has been reported to range from 0.7% 
to 1.5%, with the corresponding range for lateral epicondylitis being 0.3% to 
1.1% (Linaker, Walker-Bone et al. 1999, Bot, van der Waal et al. 2005, 
Linsell, Dawson et al. 2006, Shiri and Viikari-Juntura 2011). In the working 
populations, the annual incidence of shoulder disorders ranges from 0.5% to 
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9.4% (Roquelaure, Mariel et al. 2002, Linsell, Dawson et al. 2006, Shiue, Lu 
et al. 2008, Bodin, Ha et al. 2012, Chung, Hung et al. 2013, Gerr, Fethke et 
al. 2014), lateral epicondylitis from 0.4% to 2.1%, medial epicondylitis from 
0.1% to 1.5% (Roquelaure, Mariel et al. 2002, Descatha, Leclerc et al. 2003, 
Shiue, Lu et al. 2008, Wolf, Mountcastle et al. 2010, Chung, Hung et al. 2013, 
Descatha, Dale et al. 2013), wrist/hand soft-tissue disorders from 2.2% to 
3.1% (Roquelaure, Mariel et al. 2002, Werner, Franzblau et al. 2005), and de 
Quervain’s disease from 0.1% to 0.3% (Shiue, Lu et al. 2008, Wolf, 
Sturdivant et al. 2009, Chung, Hung et al. 2013). In working populations 
performing manually intensive tasks, the annual incidence of lateral 
epicondylitis ranges between 2% and 6.2%, medial epicondylitis  between 
1.5% and 1.8% (Shiri and Viikari-Juntura 2011, Fan, Silverstein et al. 2014, 
Gerr, Fethke et al. 2014), and that of de Quervain’s disease or wrist tendinitis 
between 1.9% and 5.4% (Leclerc, Landre et al. 2001, Harris, Eisen et al. 2011, 
Gerr, Fethke et al. 2014, Harris-Adamson, You et al. 2014).  
   In addition to the high prevalence and incidence of upper extremity 
musculoskeletal pain and disorders, the large number of healthcare 
consultations and compensation claims attributable to these conditions 
highlights the ubiquitous nature of upper extremity musculoskeletal related 
health problems all around the world (Huisstede, Bierma-Zeinstra et al. 
2006, Van Eerd, Munhall et al. 2016). Upper extremity musculoskeletal pain 
and disorders are more prevalent in the working population than in the 
general population. In particular, workers in certain occupations are at 
increased risk of suffering upper extremity musculoskeletal pain and 
disorders owing to their exposure to physical and psychosocial risk factors 
(Liaker and Walker-Bone 2015). Unfortunately, in a large proportion of the 
studies conducted in occupational populations, a representative sample of 
working population was not recruited, and their sample populations have 
been small. Moreover, the studies have often applied various case definitions 
for upper extremity musculoskeletal disorders.  
 
 2.3 RISK FACTORS FOR UESTDS  
2.3.1 BIOLOGICAL FACTORS 
2.3.1.1 Sex 
Upper extremity pain  
In general, women report upper extremity pain (Palmer, Cooper et al. 2001, 
Sundstrup, Jakobsen et al. 2014, Cho, Cho et al. 2015, Park, Kim et al. 2015, 
Soe, Laosee et al. 2015, Alavi, Makarem et al. 2016) and shoulder pain 
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(Silverstein, Fan et al. 2009, Smith, Silverstein et al. 2009, Gill, Shanahan et 
al. 2013) more commonly than men. However, some studies have found no 
sex-related differences in the prevalence of pain in the elbow (Roquelaure, 
Ha et al. 2006, Soe, Laosee et al. 2015, Thetkathuek, Meepradit et al. 2016), 
or a higher prevalence or incidence of elbow pain in men than in women 
(Palmer, Cooper et al. 2001, Bot, van der Waal et al. 2005). 
 
Upper extremity disorder  
Sex is a well-known risk factor for carpal tunnel syndrome. Previous studies 
found that women show a 2- to 3-fold higher prevalence and incidence of 
carpal tunnel syndrome than men (Atroshi, Gummesson et al. 2007, 
Bongers, Schellevis et al. 2007, Luckhaupt, Dahlhamer et al. 2013, Petit, Ha 
et al. 2015).  
   Women have also other UESTDs more frequently than men (Treaster and 
Burr 2004, Fan, Silverstein et al. 2009, Kiani, Goharifar et al. 2014). The 
prevalence and incidence of many UESTDs are higher in women than in men 
e.g. rotator cuff disorders (Walker-Bone, Palmer et al. 2004, Bot, van der 
Waal et al. 2005, Roquelaure, Ha et al. 2009, Bodin, Ha et al. 2012, Stucchi, 
Battevi et al. 2016), lateral epicondylitis (Leclerc, Landre et al. 2001, Shiri, 
Viikari-Juntura et al. 2006, Roquelaure, Ha et al. 2009, Walker-Bone, 
Palmer et al. 2012, Descatha, Dale et al. 2013, Fan, Silverstein et al. 2014, 
Sanders, Maradit Kremers et al. 2015, Stucchi, Battevi et al. 2016), medial 
epicondylitis (Walker-Bone, Palmer et al. 2004, Shiri, Viikari-Juntura et al. 
2006, Walker-Bone, Palmer et al. 2012), and wrist tendinitis or de 
Quervain’s disease  (Walker-Bone, Palmer et al. 2004, Wolf, Sturdivant et al. 
2009, Harris, Eisen et al. 2011).  
   Overall, women are at a higher risk of experiencing upper extremity pain 
and disorders than men. The differences between the sexes can be due to 
several factors, for example pain sensitivity may differ between men and 
women (Mapplebeck, Beggs et al. 2016). In addition to a sex difference in 
hormonal effects in the upper extremity (Toesca, Pagnotta et al. 2008), 
women may also respond differently to physical and psychosocial stressors in 
their daily activities and work-life (Hooftman, van Poppel et al. 2004, 
Wijnhoven, de Vet et al. 2006). Although, the sex differences can partly be 
due to confounding factors there is one report claiming that they do not 
disappear after adjustment for known confounding factors (Treaster and 
Burr 2004). The differences in exposure to physical and psychosocial factors 
between men and women seem to play only a small role in the sex difference 
in the risk of upper extremity disorders (de Zwart, Frings-Dresen et al. 2001, 
Hooftman, van Poppel et al. 2004, Hooftman, van der Beek et al. 2009).  
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2.3.1.2 Age 
Age is commonly associated with upper extremity pain and disorders. In 
general, the occurrence of upper extremity pain and disorders increases with 
age. The prevalence of chronic upper extremity pain (Gummesson, Atroshi et 
al. 2003, Herin, Vezina et al. 2014, Meroni, Scelsi et al. 2014, Pelissier, 
Fontana et al. 2014, Zoer, Frings-Dresen et al. 2014, Kaliniene, Ustinaviciene 
et al. 2016), persistent upper extremity pain (Palmer, Reading et al. 2008), 
and shoulder pain (Miranda, Viikari-Juntura et al. 2001, Bot, van der Waal et 
al. 2005) increases with age, particularly after the age of 40-45 years.  
   In the general population, the prevalence of upper extremity disorders 
increases noticeably after the age of 45 years (Walker-Bone, Palmer et al. 
2004, Salaffi, De Angelis et al. 2005, White, Titchener et al. 2014), while in 
the working population, the risk increases after the age of 30 years 
(Roquelaure, Ha et al. 2009). Moreover, the risk of shoulder disorders 
increases after the age of 40 years (Roquelaure, Ha et al. 2006, Bodin, Ha et 
al. 2012, Stucchi, Battevi et al. 2016) and is highest between 40 and 64 years 
(Bot, van der Waal et al. 2005, Greving, Dorrestijn et al. 2012, White, 
Titchener et al. 2014). A linear relationship has been observed between age 
and the prevalence of shoulder tendinopathy (Walker-Bone, Palmer et al. 
2004, Lin, Lin et al. 2015, Sansone, Meroni et al. 2015), suggesting that there 
may be a gradual degeneration of the rotator cuff with age and also 
highlighting the chronic nature of rotator cuff tendinopathy (Teunis, 
Lubberts et al. 2014). Moreover, in a study of arthroscopic rotator cuff repair, 
rotator cuff tendons were more severely injured in subjects over 60 years of 
age compared with the younger patients, pointing to a significant effect of 
age on the condition of the shoulder tendons (Djerbi, Chammas et al. 2015). 
Similarly, after the age of 35-40 years, the prevalence of lateral epicondylitis 
and wrist tendinopathy increases noticeably (Roquelaure, Ha et al. 2006, 
Stucchi, Battevi et al. 2016). The incidence of lateral epicondylitis peaks 
between ages 40 and 60, levelling off at older ages (Shiri and Viikari-Juntura 
2011, Herquelot, Guéguen et al. 2013, Fan, Silverstein et al. 2014, Sanders, 
Maradit Kremers et al. 2015).  In some working populations, however, 
younger workers may have a disproportionally higher risk of experiencing 
distal upper extremity disorders, such as wrist tendinopathy, compared with 
their older colleagues (Dale, Ryan et al. 2015). 
   Several age-related changes including degenerative changes, impaired 
blood circulation, alterations of metabolism, prolonged healing process, 
slower resolution of hyperalgesia after traumatic injury, and decreased pain 
tolerance (Gibson and Farrell 2004) may all play roles in upper extremity 
pain and disorders. Moreover, inflammatory activity mediated by the 
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interleukin 1 family has been linked to the effects of aging (Dinarello 2006) 
on upper extremity pain and disorders. Exposure to occupational factors may 
also potentiate the effects of ageing on UESTDs. 
 
2.3.2 PHYSICAL AND PSYCHOSOCIAL FACTORS AT WORK 
2.3.2.1 Physical factors at work 
Already in 2004, Punnett and Wegman concluded that there was enough 
evidence from epidemiological and experimental studies to support a causal 
role of physical risk factors at work, such as high force demands and 
repetitive work, and especially their combination, in upper extremity 
disorders (Punnett and Wegman 2004). Since then, some studies have 
revealed that UESTDs are more common in the dominant in comparison 
with the non-dominant hand (Shiri, Varonen et al. 2007, Fan, Silverstein et 
al. 2014), further supporting the hypothesis that physical loads play a role in 
the etiology of UESTDs. More recent reviews (van Rijn, Huisstede et al. 2010, 
Mayer, Kraus et al. 2012) have suggested that heavy lifting, forceful manual 
exertion, repetitive movements, working with hands above shoulder level 
and the use of vibrating hand tools are all associated with shoulder pain and 
disorders.  
   Physical load factors which have been linked with epicondylitis include 
forceful activities, forearm pronation, high force combined with high 
repetition or awkward postures of the wrist (Shiri and Viikari-Juntura 2011, 
Bodin, Ha et al. 2012, Descatha, Dale et al. 2013, Fan, Silverstein et al. 2014). 
Wrist bending, high force, twisting, and pinch gripping are tasks considered 
to increase the risk of tendon disorders in the wrist (Harris, Eisen et al. 2011, 
Petit Le Manac'h, Roquelaure et al. 2011, Pullopdissakul, Ekpanyaskul et al. 
2013).  
   Some studies among manufacturing workers, for instance, have not 
detected an association between repetition, high force or awkward postures 
and lateral epicondylitis (Pullopdissakul, Ekpanyaskul et al. 2013) or 
between wrist bending and heavy gripping and wrist tendinopathy (Harris-
Adamson, You et al. 2014). Surprisingly, one study found evidence that 
combined wrist extension and heavy power grip conferred protection against 
wrist tendinopathy (Harris-Adamson, You et al. 2014). However, a recent 
meta-analysis of five prospective cohort studies stated that combined 
biomechanical exposure involving the wrist and/or elbow increased the 
incidence of lateral epicondylitis by 2.6 fold (95% CI 1.9-3.5)(Descatha, Albo 
et al. 2016). 
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   In conclusion, most studies have found an association between physical 
load factors at work and UESTDs. Research results regarding some physical 
exposures and some upper extremity disorders are not in full agreement; this 
may be due to differences in the methods of assessing physical exposures as 
well as the excessively small and selected populations examined in some of 
the studies. Overall, the literature points to a strong and causal relationship 
between physical work load factors and UESTDs. Therefore, physical work 
load factors need to be taken into consideration in epidemiological studies on 
UESTDs.    
 
2.3.2.2 Psychosocial factors at work 
The role of psychosocial factors at work in UESTDs is unclear (Bongers, 
Ijmker et al. 2006). The job demand-control-support model (Karasek, 
Brisson et al. 1998, Bongers, Ijmker et al. 2006, Park and Jang 2010) has 
been most often tested. When one considers the work related psychosocial 
factors, then high job demands, low job control, poor co-worker or 
supervisor support, low job satisfaction and low job security have all been 
found to be associated with UESTDs (Werner, Franzblau et al. 2005, van 
Rijn, Huisstede et al. 2010, Shiri and Viikari-Juntura 2011, Gerr, Fethke et al. 
2014). However, some of the study results have been inconsistent (Bongers, 
Ijmker et al. 2006, van Rijn, Huisstede et al. 2009, van Rijn, Huisstede et al. 
2010) and some have had limited statistical power (Haahr and Andersen 
2003, Fan, Silverstein et al. 2009, Gerr, Fethke et al. 2014). Moreover, 
cohort studies have shown no or only modest effects of psychosocial factors 
on upper extremity disorders (Bongers, Ijmker et al. 2006, Bugajska, 
Zołnierczyk-Zreda et al. 2013). A review of longitudinal studies of neck and 
shoulder symptoms, suggested an association between job demand-control-
support model variables, such as low control and high job strain and 
shoulder pain (Kraatz, Lang et al. 2013).  
   In summary, studies on the role of work related psychosocial factors in 
upper extremity pain or disorders have reported inconsistent results.  
Psychosocial factors should be taken into consideration in epidemiological 
studies on upper extremity disorders, especially in studies investigating non-
specific upper extremity pain.  
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2.3.3 LIFESTYLE AND METABOLIC FACTORS IN UESTDS 
2.3.3.1 Obesity 
Overall, 11% of the world’s men and 15% of its women were obese in 2014 
(NCD-RisC 2016). Obesity has been linked with a large number of health 
problems (Collaborators 2016). The role of obesity is well-known in carpal 
tunnel syndrome (Shiri, Pourmemari et al. 2015), however, its effect on other 
UESTDs is uncertain.  
   In addition to its role as an energy storage site, adipose tissue functions as 
an organ that produces a range of biologically active mediators inducing a 
state of systemic chronic low grade inflammation in obese individuals. An 
earlier systematic review found an association between BMI and incident 
shoulder pain (Viikari-Juntura, Shiri et al. 2008). This was later supported 
by a longitudinal working population study, where high BMI values predicted 
incident severe shoulder pain (Descatha, Teysseyre et al. 2012). 
Furthermore, high BMI and excessive body fat per cent have been postulated 
to play a role in rotator cuff tear (Wendelboe, Hegmann et al. 2004, Gumina, 
Candela et al. 2014, Djerbi, Chammas et al. 2015). There are two cross-
sectional studies which detected associations between the BMI value and 
elbow and wrist pain (Pelissier, Fontana et al 2014, Kin, Suh et al. 2015). 
Moreover, several reports found evidence that overweight or obesity may be 
related with upper extremity tendinopathy (Werner, Franzblau et al. 2005) 
or wrist tendinitis (Leclerc, Landre et al. 2001, Stucchi, Battevi et al. 2016). A 
general population study detected an association between an increased waist 
hip ratio and medial epicondylitis in women (Shiri, Viikari-Juntura et al. 
2006), whereas a working population study only found evidence of a possible 
higher risk of UESTDs in obese men (Roquelaure, Ha et al. 2009).  
   Several studies, however, do not support any role for overweight or obesity 
in upper extremity pain or disorders. Some investigators did not detect any 
association between the BMI value and the prevalence of shoulder, elbow or 
wrist pain (Bodin, Ha et al. 2012, Pelissier, Fontana et al. 2014, Sundstrup, 
Jakobsen et al. 2014, Soe, Laosee et al. 2015, Kaliniene, Ustinaviciene et al. 
2016) or incident shoulder pain (Gill, Shanahan et al. 2013). Incongruously, 
a study of a working population found an association of BMI with moderate 
but not with severe shoulder pain (Descatha, Dale et al. 2013). Moreover, the 
abovementioned systematic review did not observe any association between 
BMI and rotator cuff disorders (Viikari-Juntura, Shiri et al. 2008) nor did a 
case-control study find any link between BMI and rotator cuff tears requiring 
arthroscopy (Djerbi, Chammas et al. 2015). Moreover, there are several 
reports claiming that obesity did not elevate the occurrence of any upper 
extremity disorders (Descatha, Roquelaure et al. 2007), epicondylitis 
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(Walker-Bone, Palmer et al. 2012, Descatha, Dale et al. 2013, Herquelot, 
Bodin et al. 2013, Titchener, Fakis et al. 2013), de Quervain’s disease (Petit 
Le Manac'h, Roquelaure et al. 2011), or wrist tendinopathy (Harris, Eisen et 
al. 2011).  
   Two theories have been proposed to elucidate the adiposity related 
mechanisms of tendinopathy (Abate, Schiavone et al. 2010); adiposity may 
impose a mechanical load on the load-bearing tendons, or it may affect 
tendons through systemic effects. Although obesity management may be an 
effective means of preventing serious diseases, such as non-insulin 
dependent diabetes mellitus, at present there are no studies suggesting that 
reducing body weight could protect individuals from UESTDs. 
   In conclusion, the results of the role of BMI in upper extremity pain and 
UESTDs are contradictory.  Moreover, some crucial obesity related features 
such as the presence of low-grade inflammation have not been assessed in 
UESTD studies. More investigations are needed with large general 
population samples, especially those taking relevant confounders into 
consideration. For example, gender may modify the association between 
obesity and UESTDs. Stratified analyses should be carried out in order to 
clarify the sex-related differences in these putative associations.  
 
2.3.3.2 Diabetes 
Today, diabetes can be considered as a worldwide epidemic. The global 
prevalence of diabetes has nearly doubled since 1980, rising from 4.7% to 
8.5%, reflecting an increase in associated risk factors such as overweight or 
obesity (NCD-RisC 2016). Diabetes is known to be a risk factor for rotator 
cuff disorders, adhesive capsulitis, finger flexor tenosynovitis and 
Dupuytren’s disease (Abate, Schiavone et al. 2013, Ranger, Wong et al. 2015). 
It is also a possible risk factor for carpal tunnel syndrome (Pourmemari and 
Shiri 2016). However, the role of diabetes in other UESTDs is less clear-cut. 
   Rotator-cuff tears are common in patients with diabetes (Abate, Schiavone 
et al. 2013). Moreover, a long duration of diabetes increases the risk of upper 
extremity pain, and tendinopathy in the finger flexor tendons and the rotator 
cuff (Raje, Cracknell et al. 2015, Ranger, Wong et al. 2015). One study 
investigating general population health data found that both oral antidiabetic 
drugs and insulin use were associated with rotator cuff disease (Titchener, 
White et al. 2014). Moreover, a case-control study carried out in a clinic 
specializing in managing diabetics observed a higher prevalence of shoulder 
tendinopathy among patients with type 2 diabetes compared to matched 
controls without diabetes, however, reporting only unadjusted prevalence 
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rates (Kidwai, Wahid et al. 2013). Elevated glucose levels in the pre-diabetic 
state may also be associated with a risk of rotator cuff disorders. Patients in 
an orthopaedic clinic undergoing surgery for rotator cuff tear had a 
significantly higher plasma glucose level within the normal glycaemic range 
compared to controls undergoing surgery for meniscal tear (Longo, 
Franceschi et al. 2009).  
   With regard to other UESTDs, a persistently elevated level of blood glucose 
has been associated with lateral epicondylitis in individuals over 40 years of 
age attending health check-ups (Otoshi, Takegami et al. 2015). Another 
cross-sectional study found an association between diabetes and 
epicondylitis, but only in the age and sex adjusted model (Shiri, Viikari-
Juntura et al. 2006). Moreover, a cross-sectional study reported a higher 
prevalence of lateral and medial epicondylitis and De Quervain’s disease 
among individuals with diabetes compared to those without diabetes, 
however reporting only unadjusted prevalence rates (Font, Castro-Santana et 
al. 2014). There are two cross-sectional studies and one case-control report 
that detected no association between diabetes and epicondylitis or de 
Quervain’s disease (Petit Le Manac'h, Roquelaure et al. 2011, Walker-Bone, 
Palmer et al. 2012, Titchener, Fakis et al. 2013). Furthermore, two cohort 
studies could not find any evidence for an association between diabetes and 
wrist tendinitis (Harris, Eisen et al. 2011) or upper extremity tendon 
disorders (Descatha, Roquelaure et al. 2007) . However, the results of a 
meta-analysis showed that the prevalence of tendinopathy is increased 
among subjects with diabetes (Ranger, Wong et al. 2015). Moreover, in 
individuals with diabetes, biceps and rotator cuff tendon thickness may be 
increased without any signs of clinical tendinopathy (Akturk, Karaahmetoglu 
et al. 2002). The tendon thickening encountered in individuals with diabetes 
is largely a consequence of increased formation of advanced glycation end 
products (AGEs) in tendons, which triggers the activation of catabolic 
cytokines as well as the degeneration of the tendon matrix, leading to 
symptoms and functional impairment of the affected tendon structures 
(Mäkelä, Heliövaara et al. 1999, Abate, Schiavone et al. 2013).  
   In conclusion, rotator cuff disorders are a subgroup of UESTDs consistently 
related with diabetes. In addition, elevated glucose levels within the pre-
diabetic range may have adverse effects on upper extremity tendons and may 
be related to UESTDs. However, it has to be stated that some studies 
investigating the role of diabetes in UESTDs have not been of high quality 
and furthermore, some of the associations appear to be somewhat 
inconsistent. Future studies examining the role of diabetes in UESTDs 
should recruit large general population samples and take into consideration 
all of the relevant confounders. 
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2.3.3.3 Dyslipidemia 
The role of dyslipidemia in UESTDs is uncertain. The role of a high 
cholesterol level has been highlighted in patients with familial 
hypercholesterolemia, who often present with Achilles tendon xanthomas 
and are susceptible to pain in the Achilles tendon prior to the development of 
clinically defined xanthomas. Moreover, studies conducted in mice have 
suggested that in hypercholesterolemia, deposition of microscopic 
cholesterol particles inside tendons may cause tendon inflammation and 
subsequent degeneration (Beason, Abboud et al. 2011). The results of 
individual studies on the associations between lipids and upper extremity 
disorders have been inconsistent (Abboud and Kim 2010, Longo, Franceschi 
et al. 2010). However, a systematic review and meta-analysis revealed that 
the levels of total cholesterol, low-density lipoprotein cholesterol, high 
density lipoprotein cholesterol and triglycerides were associated with 
tendinopathy (Tilley, Cook et al. 2015). Nonetheless, it seems that the meta-
analysis suffered from several limitations i.e. the reviewed studies were all 
cross-sectional or case control studies, with no prospective cohort studies 
being included. Furthermore, the included studies did not control for the 
putative associations of all known confounding factors and finally, 
publication bias was not assessed nor were the pooled estimates controlled 
for small-study effects.  
 
2.3.3.4 Leisure time physical activity 
To date, there are few certainties concerning the effects of leisure time 
physical activity and upper extremity strengthening exercises on upper 
extremity disorders. Some competitive sports activities may be responsible 
for injuries in the upper extremities (Hill, Collins et al. 2015). However, the 
role of leisure time physical activity in the primary prevention of non-specific 
and specific upper extremity disorders has not been thoroughly examined. It 
has been claimed that exercise may have a role in the secondary and tertiary 
prevention of upper extremity disorders (Desmeules, Boudreault et al. 2016). 
However, epidemiological studies examining the link between leisure time 
physical activity and upper extremity disorders have yielded inconsistent 
results. 
   Some studies suggest that regular physical activity may have beneficial 
effects on shoulder pain (van den Heuvel, Heinrich et al. 2005, Viikari-
Juntura, Shiri et al. 2008, Mork, Holtermann et al. 2013) and upper 
extremity pain (Kim, Suh et al. 2015). On the other hand, there are other 
studies reporting either no association between physical activity and non-
specific shoulder or upper extremity pain (Feng, Liang et al. 2014, Herin, 
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Vézina et al. 2014, Sundstrup, Jakobsen et al. 2014, Gremark Simonsen, 
Axmon et al. 2017), nor between physical activity and any specific upper 
extremity disorder (Werner, Franzblau et al. 2005, Shiri, Viikari-Juntura et 
al. 2006).  
   The number of studies published on physical activity and UESTDs is small 
and some of them recruited selected and small populations. Further 
prospective studies are therefore needed to elucidate the role of physical 
activity in UESTDs.  
 
2.3.3.5 Smoking 
Smoking is a known risk factor for a large number of health problems 
(Collaborators 2016). In 2015, throughout the world, 21.0% of men and 6.2% 
of women were current smokers (Collaborators 2016). In the same year, 
smoking was responsible for 148.6 million disability-adjusted life years 
globally and it was the second-leading risk factor for all disabilities in men 
and contributed to a large proportion of the global burden of diseases 
(Collaborators 2016). To date, however, virtually nothing is known about the 
role of smoking in upper extremity disorders.  
   There are some reports of an association of smoking with upper extremity 
pain (Gill, Shanahan et al. 2013, Mbutshu, Malonga et al. 2014, Sundstrup, 
Jakobsen et al. 2014), lateral epicondylitis (Shiri, Viikari-Juntura et al. 2006, 
Michienzi, Anderson et al. 2015), and shoulder impingement syndrome and 
rotator cuff tears (Bishop, Santiago-Torres et al. 2015, Djerbi, Chammas et 
al. 2015). On the other hand, a number of studies have not detected any 
association between smoking and upper extremity pain (Descatha, Teysseyre 
et al. 2012, Feng, Liang et al. 2014, Herin, Vézina et al. 2014, Pelissier, 
Fontana et al. 2014) or between smoking and upper extremity soft tissue 
disorders (Leclerc, Landre et al. 2001, Werner, Franzblau et al. 2005, 
Descatha, Roquelaure et al. 2007, Pullopdissakul, Ekpanyaskul et al. 2013, 
Fan, Silverstein et al. 2014).   
   The design of some of those studies which did detect a positive association 
between smoking and upper extremity disorders was cross-sectional. 
Furthermore, some of these studies did not control for all confounding 
factors. The association between smoking and an upper extremity disorder 
can be confounded by the presence of occupational factors. A systematic 
review found an association between smoking and shoulder pain or disorders 
only in certain occupational populations (Viikari-Juntura, Shiri et al. 2008). 
Nonetheless, it is likely that smoking impairs the healing process (Ng, Huang 
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et al. 2015) and this may predispose individuals to recurrent upper extremity 
disorders (Gill, Shanahan et al. 2013). 
 
 2.4 ADIPOKINES 
Adipokines are a family of inflammatory mediators classified according to 
their production from adipose tissue and macrophages residing in fat 
(Abella, Scotece et al. 2014). In addition to the classical pro-inflammatory 
cytokines released from fat tissue such as interleukins 1 and 6 and tumor 
necrosis factor alpha, the adipokine family now contains several recently 
discovered proteins such as leptin, adiponectin, resistin and visfatin (Lago, 
Dieguez et al. 2007). These newly characterized adipokines are 
multifunctional proteins that are participants in the low-grade inflammation 
encountered in obese subjects and they have been linked to the pathogenesis 
of metabolic syndrome and obesity related diseases (Abella, Scotece et al. 
2014). Moreover, adipokines can be divided according to their ability to 
induce mainly either pro-inflammatory or anti-inflammatory effects. 
Adipokines modulate a wide range of inflammatory and autoimmune 
processes, which means that they have been implicated in many serious 
illnesses, for instance rheumatic diseases. A role of adipokines has been 
postulated in degenerative joint diseases, specifically rheumatoid arthritis 
and osteoarthritis (Abella, Scotece et al. 2014). The role of the recently 
described adipokines in UESTDs is unknown. 
 
2.4.1 LEPTIN 
Leptin is a protein mainly produced by adipocytes. Its serum levels correlate 
with obesity and its expression is higher in women than men (Lago, Dieguez 
et al. 2007, Krysiak, Handzlik-Orlik et al. 2012). Leptin induces catabolic 
activity in the cartilage such that its expression is higher in osteoarthritic 
cartilage than in normal cartilage (Poonpet and Honsawek 2014). Leptin 
enhances inflammation by stimulating the expression of pro-inflammatory 
cytokines in pathological conditions such as rheumatoid arthritis and 
ulcerative colitis and also in insulin resistance (Lago, Dieguez et al. 2007). 
An association has been reported between leptin and pain in the lower back 
(Shiri, Solovieva et al. 2008) and pain related to arthrosis in the shoulder 
joint and hand (Massengale, Lu et al. 2012, Gandhi, Perruccio et al. 2013). 
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2.4.2 ADIPONECTIN 
Adiponectin is a peptide that possesses both anti- and pro-inflammatory 
activities (Krysiak, Handzlik-Orlik et al. 2012). Decreased adiponectin levels 
have been related to pathological metabolic conditions, such as type 2 
diabetes mellitus, dyslipidemia, insulin resistance, and the metabolic 
syndrome (Lago, Dieguez et al. 2007, Krysiak, Handzlik-Orlik et al. 2012). 
Pro-inflammatory cytokines inhibit the expression of adiponectin in 
adipocytes (Lago, Dieguez et al. 2007). Conversely, adiponectin inhibits the 
expression of the pro-inflammatory cytokines but induces that of the anti-
inflammatory cytokines (Lago, Dieguez et al. 2007). Adiponectin may exert 
protective effects on joints through its anti-inflammatory and anabolic 
properties, but may also promote osteoarthritis by enhancing pro-
inflammatory catabolic activities in the cartilage (Poonpet and Honsawek 
2014).  An association has been found between the synovial fluid adiponectin 
level and shoulder pain, suggesting that adiponectin may have a role in pain 
(Gandhi, Perruccio et al. 2013) 
 
2.4.3 VISFATIN 
Visfatin is primarily a pro-inflammatory cytokine, associated with obesity 
and insulin resistance (Lago, Dieguez et al. 2007). Its production is induced 
by pro-inflammatory cytokines but at higher concentrations, it can stimulate 
the expression of the anti-inflammatory cytokines (Tilg and Moschen 2008). 
Studies conducted in patients with inflammatory bowel disease and 
rheumatoid arthritis found evidence of increased expression of visfatin 
(Lago, Dieguez et al. 2007). Little is known about the role of visfatin in 
common musculoskeletal disorders. The level of visfatin in synovial fluid and 
in the circulation is increased in patients with osteoarthritis (Poonpet and 
Honsawek 2014).  
 
2.4.4 RESISTIN 
Resistin is a pro-inflammatory adipokine mainly produced by circulating 
mononuclear cells and endothelial cells as well as to a limited extent by 
adipocytes in humans (Lago, Dieguez et al. 2007). Resistin induces the 
activity of pro-inflammatory cytokines and has been implicated in certain 
human diseases such as atherosclerosis, systemic lupus erythematosus, 
asthma, chronic colitis, rheumatoid arthritis and osteoarthritis (Filková, 
Haluzík et al. 2009, Krysiak, Handzlik-Orlik et al. 2012). The serum levels of 
resistin have been associated with radiographic hand osteoarthritis (Choe, 
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Bae et al. 2012) and the levels of synovial fluid resistin are elevated in 
patients with knee osteoarthritis (Koskinen, Vuolteenaho et al. 2014). 
Moreover, in subjects with  rheumatoid arthritis, the resistin levels in plasma 
and synovial fluid are increased (Krysiak, Handzlik-Orlik et al. 2012).  
 
 2.5 INFLAMMATORY MARKERS IN UESTDS 
2.5.1 MECHANISMS OF TENDON INFLAMMATION  
Inflammation is the term describing the local accumulation of fluid, plasma 
proteins and white blood cells; it may be initiated by physical injury or a local 
immune response, also known as an inflammatory response (Janeway, 
Travers et al. 2005). In the tendon, activation of an inflammatory response is 
considered to require both intrinsic and external factors interfering with 
tendon matrix homeostasis (Wang 2006). Mechanical loading, which may be 
long lasting and low-level, exceeding the tendon’s capability to adjust to the 
elevated mechanical demands, is fundamental in inducing a tendon 
inflammatory response (Riley 2005, Wang 2006).  Persistent tendon loading 
increases collagen and proteoglycan synthesis by tendon fibroblasts 
(tenocytes), reforming the tendon matrix. Eventually, there is the appearance 
of a disorganised fibril formation and rounded fibroblasts with occasional 
microscopic ruptures of tendon fibrils (Riley 2005, Wang 2006). Tenocytes 
respond to mechanical loading and matrix changes by releasing many 
inflammatory mediators, especially interleukin 1 (IL-1), that induce the 
release of cyclooxygenase 2 (COX2), triggering a primary inflammation 
associated with pain and oedema (Riley 2004, Wang 2006). Alternatively, 
cells of the innate immunity system may sense strain-associated stress 
signals such as adenosine triphosphate (ATP) through activation of specific 
purinergic receptors P2Y (G-protein coupled receptors) and P2X (ligand-
gated cation channels), stimulating the caspase-1 activating NALP3 
inflammasome to produce active IL-1β (Martinon 2008, Saïd-Sadier and 
Ojcius 2012). IL-1, IL-6 and IL-8 and tumour necrosis factor alpha (TNFα) 
are characteristic biomarkers of the innate primary inflammatory response 
expressed primarily not only by inflammatory cells but also by other cell 
types such as fibroblasts and endothelial cells (Fitzgerald, O'Neill et al. 2001, 
Janeway, Travers et al. 2005). The primary cytokines, i.e. IL-1 and the pro-
inflammatory cytokines induced by IL-1, activate inflammatory cells, e.g. 
macrophages, neutrophils and monocytes which then migrate into the injury 
site, stimulating the release of more cytokines that set in motion the process 
of tendon matrix degradation, vascular growth and fibroplasia. Tendon 
matrix remodelling is the result of the activity of the inflammatory mediators 
and is a characteristic feature of tendinopathy (Riley 2005, Wang 2006). For 
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instance, studies of rotator cuff disorders have detected a range of cytokines, 
matrix proteases and growth factors which are thought to be involved in 
matrix transformation in tendinopathy (Dean, Franklin et al. 2012).  
 
2.5.2 INTERLEUKIN 1 FAMILY 
2.5.2.1 General concepts of the interleukin 1 family  
The interleukin 1 (IL-1) family comprises pro-inflammatory cytokines such 
as IL-1 and IL-1β, IL-18 and IL-33, receptor antagonists such as IL-1Ra and 
cell associated or soluble receptors such as sIL-1RII and sST2 (Garlanda, 
Dinarello et al. 2013). IL-1α present within the cell and its secreted form, IL-
1β, are distinct molecular forms of IL-1 but with similar biological properties 
(Fitzgerald, O'Neill et al. 2001). IL-1β is a powerful inflammatory mediator 
and a key cytokine in the immunological regulation of human disease; its 
functions are controlled by negative regulators like IL1-Ra and the soluble 
decoy receptor sIL-1RII. IL-1β induces formation of prostaglandin E2 
(PGE2) by the enzyme COX2, mediating pain and edema (Lee, Kim et al. 
2004, Dinarello 2009). Other significant pro-inflammatory properties of IL-
1β are its ability to increase the expression of adhesion molecules and to 
induce chemokines and angiogenesis. Chronic IL-1 induced inflammation 
with subsequent tissue remodelling is one characteristic feature of the 
pathobiology of several musculoskeletal disorders such as rheumatoid 
arthritis, osteoarthritis and degenerative intervertebral disc disease (Le 
Maitre, Hoyland et al. 2007, Dinarello 2009). Excess body mass increases 
IL-1 production, indicating that obesity can be viewed as an inflammatory 
condition.   
   IL-18 is an important IL-1 family pro-inflammatory cytokine involved in 
inflammatory joint disease such as rheumatoid arthritis, for example by 
stimulating cartilage degeneration (Arend, Palmer et al. 2008). IL-18 is 
linked to obesity and insulin resistance (Osborn, Gram et al. 2008) but it also 
has important roles in other inflammatory diseases, e.g. in systemic lupus 
erythematosus, psoriasis, Crohn’s disease and allergy. 
   IL-33 is a pro-inflammatory cytokine; it is the ligand for the receptor ST2 
(suppression of tumorigenicity 2). Both IL-33 and ST2 are biomarkers of Th2 
responses (Arend, Palmer et al. 2008, Dinarello 2009). IL-33 contributes to 
joint inflammation and synovial hyperplasia, and is also involved in 
cardiovascular disease and certain allergic disorders such as asthma 
(Dinarello 2009). Increased levels of soluble ST2 (sST2) have been found in 
the serum of patients with inflammatory conditions such as asthma and 
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systemic lupus erythematosus as well as in the synovial fluid of patients with 
rheumatoid arthritis (Arend, Palmer et al. 2008). The soluble form of ST2 
acts as a decoy receptor of IL-33 with anti-inflammatory effects. In mice with 
collagen-induced arthritis, it was observed that an intra-articular injection of 
sST2 could attenuate the joint inflammation (Arend, Palmer et al. 2008).  
 
2.5.2.2 IL-1 family and UESTDs 
Rather few investigators have examined the role of IL-1 in UESTDs. When 
this has been done, they have generally reported increased expression of IL-1 
in different experimental settings, however some reports have been 
inconsistent. A study using a rat model mimicking work-related UESTDs, 
showed that exposure of rat forelimbs to excessive repetition increased the 
expression of IL-1 in the tendon as well as in the circulation (Barbe, Barr et 
al. 2003, Barbe, Elliott et al. 2008, Fedorczyk, Barr et al. 2010). It was also 
found that the infiltrating macrophages detected in rat peripheral forelimb 
tissues could be one source of the circulating IL-1. Inconsistently, a study 
implementing static loading of rabbit tendon detected a decline in IL-1 
expression in the tendon (Asundi and Rempel 2008). Moreover, an 
investigation of experimental epicondylitis in a rabbit model showed that 
cumulative repetitive loading did not increase the expression of IL-1 in the 
flexor digitorum tendon (Asundi, King et al. 2008).  
   In cultured human flexor digitorum tendon cells, physical loading was 
found to induce the expression of IL-1β (Tsuzaki, Bynum et al. 2003). Studies 
of subacromial bursa specimens retrieved from patients undergoing rotator-
cuff surgery have shown consistently increased expression of several proteins 
from the IL-1 family, e.g. IL-1α, IL-1β and IL-1Ra (Gotoh, Hamada et al. 
2001, Sakai, Fujita et al. 2001, Blaine, Kim et al. 2005, Voloshin, Gelinas et 
al. 2005). Increased expression of IL-18 has been observed in specimens of 
torn supraspinatus tendons as compared with intact subscapularis tendons 
(Millar, Wei et al. 2009). In addition, a study comparing samples of torn 
supraspinatus tendons with intact subscapularis tendons in the same 
shoulder, which was intended to provide a relevant way of comparing the 
expression of pro-inflammatory cytokines in chronic tendinopathy with 
those in pre-clinical tendinopathy, detected a higher expression of IL-21 
receptor in the subscapularis tendon, which may be interpreted as evidence 
of increased IL-1 family cytokine activity in early tendinopathy (Campbell, 
Smith et al. 2014).  
   There are only a few reports of IL-1 family cytokines in outpatient UESTD 
populations. A study of patients with upper extremity disorders with 
symptom duration less than 12 weeks reported a correlation between serum 
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levels of IL-1 and symptom severity scores, however, in the regression 
analyses, the association lost its statistical significance (Carp, Barbe et al. 
2007). A study of patients with rotator cuff disorder conducted by Savitskaya 
and colleagues reported a correlation between serum IL-1β and the grade of 
degeneration as assessed by ultrasound imaging, showing the highest 
concentrations in individuals having tendon ruptures (Savitskaya, Izaguirre 
et al. 2011).  
 
2.5.3 INTERLEUKIN 6 (IL-6) 
   IL-6 is a multifunctional cytokine secreted by both lymphoid and non-
lymphoid cells regulating B and T cell functions, hematopoiesis and acute 
phase reactions (Fitzgerald, O'Neill et al. 2001). Some non-lymphoid cells 
also express IL-6 for instance macrophages, chondrocytes, fibroblasts and 
endothelial cells as well as adipocytes. IL-6 is the key mediator of the 
synthesis of acute phase C- reactive protein (CRP). Together with IL-1 and 
TNFα, IL-6 is a major cytokine in the pathogenesis of rheumatoid arthritis 
(Choy 2012) and osteoarthritis, promoting the destruction in the cartilage 
and the subchondral bone layer (Wojdasiewicz, Poniatowski et al. 2014).  
Some investigators have proposed a pain modifying role for IL-6 in 
degenerative joint disease (Wojdasiewicz, Poniatowski et al. 2014) and 
fibromyalgia (Mendieta, De la Cruz-Aguilera et al. 2016). A study of recent 
onset upper extremity disorders detected a correlation between the serum 
IL-6 concentration and symptom severity (Carp, Barbe et al. 2007). 
Increased expression of IL-6 has been found in samples of subacromial 
bursas in rotator cuff disease and also in torn rotator cuff tendons (Blaine, 
Kim et al. 2005, Voloshin, Gelinas et al. 2005, Ko, Wang et al. 2008). 
Moreover, in patients that were operated for CTS, levels of serum and carpal 
flexor tendon tenosynovium IL-6 were increased when compared to control 
samples of cadavers or in patients undergoing other hand surgical 
procedures (Freeland, Tucci et al. 2002).  
 
2.5.4 INTERLEUKIN 8 (IL-8) 
   IL-8 is a pro-inflammatory chemokine produced by macrophages, 
predominantly attracting and activating neutrophils at the site of 
inflammation but also regulating other types of white blood cells such as 
basophils and lymphocytes (Fitzgerald, O'Neill et al. 2001). IL-8 is a potent 
angiogenic factor and therefore a plausible promoter of neovascularization in 
tendon disorders. IL-8 is  associated with pain in patients with fibromyalgia 
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(Mendieta, De la Cruz-Aguilera et al. 2016).  In patients with rotator cuff 
tear, the IL-8 level of shoulder joint fluid was associated with resting pain 
(Okamura, Kobayashi et al. 2015) . Moreover, there was evidence of elevated 
IL-8 expression in bursa samples of patients with adhesive subacromial 
bursitis (Yoshida, Funasaki et al. 2003). Furthermore, in patients with 
rotator cuff  disorder, the levels of serum IL-8 were associated with the grade 
of rotator cuff degeneration (Savitskaya, Izaguirre et al. 2011).  
 
2.5.5 TUMOR NECROSIS FACTOR ALPHA (TNFα) 
TNFα is a potent pro-inflammatory cytokine with diverse roles in 
inflammation and immune functions (Fitzgerald, O'Neill et al. 2001). TNFα 
levels are elevated in obesity and insulin resistance (Trayhurn, Bing et al. 
2006) and this cytokine also plays an important role in rheumatoid arthritis 
(Choy 2012) and osteoarthritis (Wojdasiewicz, Poniatowski et al. 2014). In 
osteoarthritis, the inflammatory stimulation evoked by TNFα is a potential 
pathway leading to pain induction (Lee, Ellman et al. 2013). In the above-
mentioned upper extremity overuse model, increased expression of TNFα 
was found in serum as well as in tendon specimens of rats exposed to high 
repetition movements (Barbe, Elliott et al. 2008, Gao, Fisher et al. 2013). 
Several studies of subacromial bursa specimens retrieved after rotator cuff 
disorder surgery have detected increased expression of TNFα (Dean, 
Franklin et al. 2012). An association has also been found between serum 
TNFα levels and the severity of recent onset upper extremity disorder 
symptoms (Carp, Barbe et al. 2007). 
 
2.5.6 TRANSFORMING GROWTH FACTOR BETA (TGFβ) 
TGFβ is essentially an anti-inflammatory protein (Gorelik and Flavell 2002); 
it is involved in tissue remodelling, wound repair and haematopoiesis 
(Fitzgerald, O'Neill et al. 2001). TGFβ inhibits cell growth and promotes 
tissue fibrotic transformation of tissues by inducing collagen synthesis and 
angiogenesis, features typically seen in tendon disorders (Kovacs and 
DiPietro 1994). The role of TGFβ has been very little studied in UESTDs. In a 
rodent upper extremity overuse model, serum and tendon TGFβ was 
increased along with epitendon thickening in those rats exposed to excessive 
repetition (Gao, Fisher et al. 2013). An increased expression of TGFβ was 
found in subacromial bursa specimens of subjects with rotator cuff tears 
(Dean, Franklin et al. 2012).  
  34 
 
2.5.7 C-REACTIVE PROTEIN (CRP) 
CRP is an acute phase protein produced by the liver and induced mainly by 
IL-6 (Black, Kushner et al. 2004). In human tenocytes, however, CRP gene 
expression may be impaired by the presence of IL-6 (Busch, Girke et al. 
2013). CRP functions as an innate immunity complement activator 
promoting phagocytosis through opsonisation (Black, Kushner et al. 2004). 
CRP has both anti- and pro-inflammatory properties i.e. it can induce the 
secretion not only of anti-inflammatory mediators IL-1Ra and IL-10, but also 
that of the pro-inflammatory cytokines IL-1, IL-6, IL-8, IL-18 and TNFα 
(Black, Kushner et al. 2004). CRP expression is increased in obesity and this 
phenomenon has been implicated in the chronic systemic low-grade 
inflammation associated with that condition (Debnath, Agrawal et al. 2016). 
An elevated circulating level of CRP (using cut point of 3mg/l) has been 
associated with an increased risk of ischaemic heart disease (Verma and Yeh 
2003) and atherosclerosis (Jialal, Devaraj et al. 2004). The serum level of 
CRP increases in chronic inflammatory diseases such as rheumatoid arthritis 
(Rhodes, Fürnrohr et al. 2011). Moreover, CRP has been linked with 
osteoarthritis (Saberi Hosnijeh, Siebuhr et al. 2015). A study of patients 
undergoing knee or hip replacement found an association of CRP with pre-
operative pain severity but not with the degree of osteoarthritis (Sturmer, 
Brenner et al. 2004). In a cross-sectional study of a population of 
adolescents, no association was observed between CRP levels and 
musculoskeletal pain (Bout-Tabaku, Michalsky et al. 2015), however, in a 
population of patients with chronic kidney disease, an elevated CRP level 
correlated with the severity of chronic musculoskeletal pain (Caravaca, 
Gonzales et al. 2016). A prospective study in patients with acute sciatica 
reported an association between higher serum CRP level with acute pain but 
not with chronic low back pain (Stürmer, Raum et al. 2005). The role of CRP 
in UESTDs has received little attention so far. There is one report of patients 
with recent onset upper extremity disorders which detected an association 
between serum CRP levels and the severity of symptoms (Carp, Barbe et al. 
2007).  
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 2.6 SUMMARY OF EXISTING INFORMATION AND GAPS 
IN OUR KNOWLEDGE 
UESTDs are common health problems; previous research indicates rather 
consistently that age and physical work load factors play a role in their 
aetiology. On the other hand, the effects of lifestyle factors, e.g. physical 
exercise and smoking, and metabolic factors on UESTDs are uncertain. The 
pathological mechanisms in the process of tendon inflammation are still 
partly unresolved.  Moreover, very little is known about the role of 
adipokines and inflammatory factors in UESTDs. There is some evidence 
emerging from work conducted in upper limb overuse models in rats and 
rotator cuff samples obtained during surgery that there may be elevated pro-
inflammatory activity in UESTDs. Serum samples of selected patient 
populations have shown correlations between increased expression of pro-
inflammatory cytokines and symptom severity as well as with degree of 
shoulder tendon degeneration. Nevertheless, these findings should be viewed 
with some caution. The evidence supporting the role of inflammatory 
biomarkers in UESTDs either during their early stage or throughout their 
natural course is lacking (Gold, Hallman et al. 2015). In addition, there are 
no study reports of biomarkers that might represent potential mediators 
between metabolic risk factors and UESTDs. Finally, no specific biomarker 
analyses have yet been developed for screening or diagnostic purposes in 
UESTDs (Saxton 2000, Gold, Hallman et al. 2015). In conclusion, as the 
findings of the associations between metabolic and inflammatory factors and 
UESTDs are largely based on a limited number of studies and reveal partly 
inconsistent results, more research is needed. This thesis addresses these 
deficits by applying a clinical epidemiological approach, using a population-
based survey and also a clinical sample.  
  
  36 
 3 AIMS OF THE STUDY 
The overall aim of this study was to assess the associations of metabolic 
factors and inflammatory related parameters with UESTDs. 
The specific aims of the study were as follows: 
To estimate the prevalence of shoulder joint pain and chronic rotator cuff 
tendinitis (article I) 
To assess the associations of metabolic factors, particularly obesity, 
metabolic syndrome and adipokines with shoulder joint pain, chronic rotator 
cuff tendinitis, and pain intensity in incipient upper extremity soft tissue 
disorders (articles I-II).  
To identify circulating inflammatory biomarkers in incipient upper extremity 
soft tissue disorders (article III).  
To determine the effects of serum adipokine levels on recovery from upper 
extremity soft tissue disorders and to explore whether obesity modifies these 
effects (article IV).  
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 4 METHODS AND MATERIALS 
 4.1 STUDY POPULATION 
4.1.1 HEALTH 2000 SURVEY 
The Health 2000 Survey, a nationwide study conducted by the National 
Institute of Health and Welfare, comprised all men and women aged 30 
years or over living in Finland between autumn 2000 and spring 2001. A 
representative sample of the Finnish population was drawn by stratifying the 
population into five university hospital regions clustered into 16 health care 
districts, totalling 80 health care districts throughout the whole country. The 
15 largest health care districts were sampled with probability 1, and then the 
probability proportional to size (PPS) method was used to sample the 
remaining 65 health care districts. Persons aged 80 years or over were 
recruited by doubling the sampling fraction (Aromaa A. 2004).  
   The primary population of the Health 2000 Survey consisted of 8028 
subjects, of them 6354 (80%) participated in the home interview and the 
health examination. In the current study, subjects with missing information 
about shoulder disorders (N = 24) and those with clinically diagnosed 
rheumatoid arthritis and a positive rheumatoid factor (N = 93) were 
excluded and thus finally 6237 (78%) subjects were included in the analysis. 
 
4.1.2 UPPER EXTREMITY PROJECT 
4.1.2.1 Patients 
The patients’ recruitment was carried out in the Finnish Institute of 
Occupational Health (FIOH) between spring 2006 and fall 2008. Three 
occupational health service units in Helsinki delivering primary health care 
referred eligible patients who had sought medical advice for incipient 
UESTDs for further examination to the Work Physiatry Clinic of FIOH. 
Altogether 224 subjects were examined, of them 61 were excluded due to 
disqualification or missing information on fasting serum samples (see 
below). Ultimately, 163 actively working subjects with symptom duration of 
less than one month and meeting diagnostic criteria based on physical 
examination were included.  
   We excluded subjects whose main problem was a spinal disorder, advanced 
osteoarthritis, autoimmune disease, fibromyalgia, malignancy, or who had 
history of recent injury, former surgery related to the current problem, or the 
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presence of a deformity. Aiming to eliminate chronic disorders, we excluded 
also subjects with work absence for two weeks or longer prior to the medical 
examination, those needing sick leave immediately after the examination and 
those with three or more pain episodes of the same disorder during the past 
year. Furthermore, we excluded six patients with carpal tunnel syndrome, 
leaving 163 patients for the analysis.  In addition to baseline, information 
was gathered at 4 weeks, 8 weeks and 12 weeks follow-up.  
 
4.1.2.2 Controls 
A control group was recruited from the Finnish Institute of Occupational 
Health. The controls were healthy volunteers free from upper extremity 
symptoms (N = 42).  The working environment of the controls was largely 
comparable with the patients. Moreover, patients and controls were matched 
at group level for both age and sex. 
 
 4.2 OUTCOMES 
4.2.1 HEALTH 2000 SURVEY 
Before starting the study, all project nurses and physicians were trained to 
carry out the clinical assessments. All study participants were examined with 
a structured protocol, where nurses interviewed each individual about 
musculoskeletal symptoms and physicians carried out a standardized 
physical examination. Joint symptoms were inquired with a general question 
"Have you had joint pain, ache or motion tenderness in one or more joints 
during the preceding 30 days?" After this, the individual was asked to point 
out the painful joint regions on a manikin. Pain during the preceding 30 days 
in either the right or left shoulder joint was defined as unilateral shoulder 
joint pain and pain in both shoulders as bilateral.   
   Chronic rotator cuff tendinitis was defined as a history of pain in the 
rotator cuff region lasting for at least 3 months, as well as pain during the 
preceding month, and pain in one or more active resisted movements 
(abduction, external rotation, internal rotation) and/or painful arc in 
shoulder abduction. The examining physician classified the diagnostic 
certainty into two levels; possible with the two last criteria and probable with 
only one of the two last criteria being met, however these categories were 
combined in the analysis.  
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4.2.2 UPPER EXTREMITY PROJECT 
Upper extremity soft tissue disorders 
UESTDs were determined by a standardized protocol comprising symptom 
questions and clinical examination manoeuvers by a physician. 
Subsequently, two specialists in physical medicine and rehabilitation 
confirmed the clinical diagnosis according to the predetermined criteria. 
Specific upper extremity disorders included disorders of the shoulder 
(rotator cuff tendinitis, impingement syndrome), elbow (lateral and medial 
epicondylitis) and wrist (De Quervain’s disease, peritendinitis, tenosynovitis 
and nerve entrapments). Non-specific upper limb pain was defined as local 
pain in the shoulder, elbow, forearm or wrist in the absence of specific upper 
extremity soft tissue disorder, or only partially meeting the diagnostic 
criteria for a specific upper extremity disorder.  
 
Intensity of upper extremity pain 
Upper extremity pain during the preceding week was assessed with a visual 
analogue scale (0=no pain, 100= highest pain intensity possible). In the 
analyses, pain intensity was dichotomized at the highest tertile (cut-point 
60). 
 
Recovery from UESTDs  
Recovery from UESTDs was assessed by phone interviews at 2, 8 and 12 
weeks follow-up. The question had four alternative responses: “recovered 
fully”, “recovered substantially”, “remained unchanged”, and “exacerbated”. 
In the analysis, recovery was dichotomized into "recovered fully or 
substantially" and “remained unchanged or exacerbated”.  
 
 4.3 INDEPENDENT VARIABLES 
4.3.1 HEALTH 2000 SURVEY 
Individual factors included age, sex, and years of education. Smoking status 
was classified as never, former, occasional and current smoking. Pack years 
were estimated by multiplying the number of smoking years by the number 
of cigarettes smoked per day / 20. Alcohol consumption was grouped into 
four levels; none, light, moderate and heavy according to cut-points of equal-
sized distributions of serving portions or drinks. Leisure time physical 
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activity was assessed by a single question and classified into three groups: <1, 
2–3, and >4 times per week. 
   Information on physical workload factors was gathered during the 
interview and included current exposure to the following factors: working 
with hands above the shoulder level for at least 1h/ day, manual handling of 
loads heavier than 5 kg at least 2 times/minute for a minimum of 2h/day, 
manual handling of loads heavier than 20 kg for at least 10 times/day, 
working with a vibrating tool for at least 2h/day, work demanding high 
handgrip forces for at least 1 h/day, and repetitive movements of the hands 
or wrists for at least 2h/day. 
   Height, weight, waist circumference, and hip circumference were measured 
(WHO 2000). BMI was classified into underweight (BMI <18.5), normal 
weight (BMI 18.5-24.9), overweight (BMI 25.0-29.9) and obesity (BMI 
>30.0). Waist circumference was classified into three groups; normal (< 94.0 
cm for men and <80.0 cm for women), overweight (94.0-101.9 cm for men 
and 80.0-87.9 cm for women), and abdominal obesity (>102.0 cm for men 
>88.0 cm for women). Waist-to-hip ratio was also classified into three levels: 
<0.9, 0.9-1.0, >1.0 for men, and <0.8, 0.8-0.9 and >0.9 for women. 
   The diagnosis of diabetes mellitus was based on fasting blood glucose ≥7.0 
mmol/l (126 mg/dL) (Alberti and Zimmet 1998), and/or a known previous 
diagnosis of diabetes mellitus, or intake of glucose lowering medication. 
Insulin resistance (HOMA-IR) was determined as serum insulin x glucose/ 
22.5. We defined metabolic syndrome according to the criteria of the 
American Association of Clinical Endocrinologists (Einhorn, Reaven et al. 
2003) when at least 3 of the following criteria were present: 1) central obesity 
(waist circumference > 102 cm for men and > 88 cm for women); 2) high 
fasting triglycerides (>150 mg/dL); 3) low HDL cholesterol (< 40 mg/dL for 
men and < 50 mg/dL for women); 4) high blood pressure (systolic blood 
pressure > 130 mm Hg or diastolic blood pressure > 85 mm Hg); and 5) 
impaired fasting glucose (>110 mg/dL). 
 
4.3.2 UPPER EXTREMITY PROJECT 
Individual factors included age, sex, smoking (never, former, occasional or 
current), and intake of antihypertensive, glucose lowering, antidepressive 
and lipid lowering medication and painkillers. Frequency of alcohol 
consumption was inquired and grouped into two levels: <2 times per week, 
or >2 times per week. The number of sessions of physical exercise per week 
for at least 30 minutes causing sweating or shortness of breath was inquired 
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and used to classify frequency of physical exercise into none or occasional, 1-
2 times/week, or ≥3 times per week. 
   Height, weight, waist circumference and hip circumference were measured 
by standard procedures (WHO 2000) and body fat composition by the 
bioimpedance technique. BMI was calculated and grouped into underweight 
(BMI <18.5), normal weight (BMI 18.5-24.9), overweight (BMI 25.0-29.9) 
and obese (BMI >30.0). Patients’ and controls’ fasting blood samples were 
collected to measure serum levels of glucose, cholesterol, triglycerides and 
high sensitive C-reactive protein (CRP).  
   The patients were enquired by the examining physician about the 
frequency of heavy lifting, duration of working with hand above shoulder 
level, prolonged forceful gripping, as well as pinch grip that either required 
exertion or a deviated wrist posture, and the use of vibrating tools. Each 
factor was dichotomised using a cut-off point of being exposed for ≥10% of 
the work time during a workday. 
   We assessed job strain using the 14-item Job Content Questionnaire 
(Karasek, Brisson et al. 1998), and dichotomized job demands and job 
control at the median to create a job strain variable. Fear-avoidance beliefs 
were assessed using four items adapted from the study of Waddell and co-
workers (Waddell, Newton et al. 1993). We used the score of 18 as the cut-off 
to define elevated fear-avoidance beliefs.  
   We applied the patient health questionnaire-9 (PHQ-9) to assess 
depressive symptoms (Kroenke, Spitzer et al. 2001), and used the cut-off 
value of > 5 to define mild to severe depressive symptoms. Sleep disturbance 
was defined as often or always waking during the night or in the early hours. 
We defined the metabolic syndrome according to the revised National 
Cholesterol Education Program (NCEP) classification (Grundy, Brewer et al. 
2004), fulfilling at least three of the following criteria: 1) central obesity 
(waist circumference ≥ 102 cm for men and ≥88 cm for women); 2) high 
fasting triglycerides (> 150 mg/dL or drug treatment for elevated 
triglycerides); 3) low HDL cholesterol (< 40 mg/dL for men and < 50 mg/dL 
for women, or drug treatment for reduced HDL); 4) high blood pressure 
(systolic blood pressure > 130 mm Hg or diastolic blood pressure > 85 mm 
Hg or antihypertensive drug treatment with a history of hypertension); and 
5) impaired fasting glucose (>100 mg/dL or drug treatment for elevated 
glucose values).  
   We determined several serum inflammatory biomarkers interleukin 1 alpha 
and beta (IL-1α and IL-1β), interleukin 1 receptor antagonist (IL-1Ra), 
soluble interleukin 1 receptor 2 (sIL-1RII), interleukin 33 (IL-33), sST2, 
interleukin 6 (IL-6), interleukin 8 (IL-8), interleukin 18 (IL-18), and tumor 
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necrosis factor α (TNFα), and four adipokines - leptin, adiponectin, resistin 
and visfatin by Luminex® and enzyme linked immunosorbent assays. 
 
 4.4 STATISTICAL ANALYSES 
4.4.1 HEALTH 2000 SURVEY 
Population weighting was used for prevalence rates, odds ratios (OR), and 
their confidence intervals (CI) to correct for any disproportionate selection of 
population subsets and to adjust for age, sex, residential district, and 
language distributions in order to represent the Finnish general population. 
We conducted a multinomial logistic regression for shoulder joint pain (no, 
unilateral, bilateral) and a logistic regression for chronic rotator cuff 
tendinitis. The estimates were controlled for age, sex, education, working 
with hands above the shoulder level, manual handling of loads heavier than 5 
kg or heavier than 20 kg, working with a vibrating tool, work demanding 
high handgrip forces, and repetitive movements of the hands or wrists. We 
also performed sex-specific analyses. Stata, version 10 software was used to 
conduct survey analyses. 
 
4.4.2 UPPER EXTREMITY PROJECT 
Cross-sectional design 
We devised logistic regression models to study the associations of metabolic 
factors and adipokine levels with upper extremity pain intensity. We first 
performed six age- and sex-adjusted regression analyses to identify 
significant factors within each of the following families: 1) weight-related 
factors, 2) lipids, 3) other metabolic factors, 4) adipokines, 5) lifestyle factors 
other than overweight/obesity (smoking, alcohol consumption and physical 
exercise), and 6) work-related factors. The final regression model included 
all significant factors derived from the six age- and sex-adjusted models. We 
also performed a stratified analysis to assess whether the effects of 
adipokines differed between overweight and non-overweight subjects. We 
used SPSS, version 20.0 software to perform the analysis.     
 
Case control design 
We used chi-squared test for categorical variables and unpaired two-sample t 
test (Welch's test) for continuous variables to test for a statistically 
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significant (two-tailed P <0.05) difference between cases and controls. We 
conducted an unconditional logistic regression to investigate the associations 
between cytokine concentrations and UESTDs. The estimates were 
controlled for age, sex, smoking, body mass index, sleep disturbance, 
physical activity and alcohol consumption. Mean BMI differed between the 
cases and controls. We therefore used a stratified analysis to explore whether 
the observed associations between cytokines and UESTDs are due to BMI. 
Moreover, we corrected for multiple testing using the Bonferroni correction. 
We used Stata, version 8.2 software in the analysis.      
 
Longitudinal design 
We used generalized estimating equation (GEE) to study the effects of 
adipokine levels on recovery from UESTDs. The estimates were controlled 
for age, sex, follow-up time, physical activity, alcohol consumption, smoking, 
body mass index, sleep disturbance and job strain. We performed subgroup 
analyses for tendon disorders and for non-specific upper limb pain. 
Moreover, we explored whether the effects of the adipokines on the recovery 
from UESTDs were modified by overweight/obesity using a stratified 
analysis. We used Stata, version 10 software for the analysis.  
 
 4.5 ETHICAL STATEMENT 
The Coordinating ethics committee of Helsinki University Hospital district 
approved this study on August 15th 2005. A supplementary ethical approval 
was given on April 3rd 2007 regarding the serum biomarker study as well as 
allowing for recruiting a control group.  
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 5 RESULTS 
 5.1 HEALTH 2000 SURVEY (STUDY I) 
The mean age of the study population was 52 years and the mean BMI was 
26.2 kg/m2 (Table 1). One fourth of the subjects were current smokers and a 
similar percentage exercised four times or more per week. Sixteen percent of 
the subjects reported shoulder joint pain and 2.8% had possible or probable 
chronic rotator cuff tendinitis. 
 
 
Table 1  Background characteristics of the study subjects who were free from 
rheumatoid arthritis (N=6,237), weighted proportion or mean, Health 2000 Survey, 2000-2001   
Characteristic %  Mean 
    
Mean age    51.9 
Years of education    11.3 
Body mass index (kg/m2)    26.2 
Waist circumference (cm)   92.9 
Hip circumference (cm)   101.5 
Insulin resistance   2.5 
Current smoking 25.9   
Exercise (times/week)    
  <1 40.9   
  2–3 32.6   
  >4 26.5   
Metabolic syndrome 30.5   
Diabetes    
  Type 1 0.6   
  Type 2 5.0   
High C-reactive protein (>3 mg/L) 16.7   
Shoulder joint pain    
  Unilateral 9.5   
  Bilateral 6.3   
Chronic rotator cuff tendinitis    
  Possible 1.6   
  Probable 1.2   
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5.1.1 SHOULDER JOINT PAIN (STUDY I) 
Body mass index, waist circumference and waist-to-hip ratio were associated 
with both unilateral and bilateral shoulder joint pain after adjustment for 
age, sex, education and physical workload factors (Table 2). Moreover, 
individuals with type 2 diabetes had an increased prevalence of shoulder 
joint pain. Smoking, leisure time physical activity, metabolic syndrome, 
insulin resistance and C-reactive protein were not associated with unilateral 
or bilateral shoulder joint pain.  
   In the sex-specific analyses, current smoking was associated with unilateral 
shoulder pain in men, with the strongest association detected in those men 
who had smoked more than 20 pack-years (OR = 1.9, 95% CI 1.3-2.9). 
Women who had smoked for 10-20 pack-years showed an increased 
prevalence of bilateral shoulder pain (OR = 1.8, 95% CI 1.0-3.1). With respect 
to weight related factors, abdominal obesity in terms of waist circumference 
or waist-hip ratio showed the strongest associations with unilateral shoulder 
pain in men (OR = 1.8, 95% CI 1.3-2.5 for waist circumference and 2.4, 95% 
CI 1.3-4.4 for waist-hip ratio) and bilateral shoulder pain in women (OR = 
2.5, 95% CI 1.6-4.0 for waist circumference and 1.8, 95% CI 1.1-3.1 for waist-
hip ratio). The metabolic syndrome (OR = 1.5, 95% CI 1.2-1.9) and type 2 
diabetes (OR = 1.7, 95% CI 1.0-2.9) were associated with unilateral shoulder 
pain in men. High CRP values were associated with bilateral shoulder pain in 
women (OR = 1.4, 95% CI 1.0-2.1). 
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Table 2  Odds ratios of unilateral or bilateral shoulder joint pain with respect to lifestyle 
and metabolic factors, Health 2000 Survey, 2000-2001 
Characteristic Unilateral  Bilateral 
OR* 95% CI  OR* 95% CI 
Smoking status      
  Never smoker 1   1  
  Former smoker 1.02 0.82-1.26  0.98 0.74-1.29 
  Occasional smoker  1.01 0.64-1.60  0.56 0.27-1.19 
  Current smoker 1.09 0.86-1.39  0.84 0.60-1.17 
Exercise (times/week)      
  <1 1   1  
  2–3 1.22 0.99-1.50  0.86 0.66-1.13 
  >4 0.80 0.63-  0.79 0.60-1.05 
Body mass index       
  Normal  1   1  
  Underweight 0.34 0.07-1.54  0.34 0.04-2.69 
  Overweight 1.24 1.03-1.49  1.24 0.94-1.63 
  Obese 1.40 1.09-1.79  1.48 1.06-2.08 
Waist circumference      
  Normal  1   1  
  Increased  1.65 1.31-2.08  1.35 0.99-1.82 
  Obese  1.62 1.30-2.03  1.66 1.25-2.20 
Waist-to-hip ratio      
  Normal 1   1  
  Increased 1.17 0.91-1.52  1.37 0.90-
  Obese 1.40 1.04-1.88  1.82 1.17-2.84 
Metabolic syndrome  1.14 0.95-1.35  1.15 0.93-1.44 
Insulin resistance, per each standard deviation 1.01 0.99-1.02  1.01 0.99-1.02 
Diabetes      
  Type 1 -   1.87 0.53-6.53 
  Type 2 1.48 1.08-2.04  1.55 0.99-2.43 
C-reactive protein (high >3 mg/L vs. low <3 mg/L)  1.15 0.90-1.45  1.29 0.97-1.71 
*Controlled for age, sex, education and physical load factors 
 
 
5.1.2 CHRONIC ROTATOR CUFF TENDINITIS (STUDY I) 
With respect to weight-related factors, only waist circumference was 
associated with chronic rotator cuff tendinitis after adjustment for age, sex, 
education and physical workload factors (Table 3). Smoking, leisure time 
physical activity, metabolic syndrome, insulin resistance, diabetes and C-
reactive protein were not associated with chronic rotator cuff tendinitis. In 
the sex-specific analysis, in our male subjects, increased waist circumference 
(OR = 3.8, 95% CI 1.1-3.5) and type 1 diabetes (OR = 4.7, 95% CI 1.1-20.3) 
were associated with chronic rotator cuff tendinitis.  
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Table 3  Odds ratios of chronic rotator cuff tendinitis by lifestyle and metabolic factors, 
Health 2000 Survey, 2000-2001    
 
Characteristic  OR* 95% CI 
Smoking status   
  Never smoker 1  
  Former smoker 1.14 0.78-1.67 
  Occasional smoker  0.43 0.15-1.24 
  Current smoker 0.85 0.50-1.41 
Exercise (times/week)   
        ≤1 1  
        2–3 1.31 0.91-1.89 
        ≥4 1.09 0.74-1.62 
Body mass index    
  Normal  1  
  Underweight  0.50 0.07-3.66 
  Overweight  1.28 0.88-1.85 
  Obese 1.48 0.93-2.37 
Waist circumference   
  Normal 1  
  Increased 1.79 1.15-2.79 
  Obese 1.49 0.98-2.27 
Waist-to-hip ratio   
  Normal 1  
  Increased 1.06 0.64-1.75 
  Obese 1.24 0.71-2.15 
Metabolic syndrome 0.91 0.66-1.25 
Insulin resistance, per each standard deviation increase 0.99 0.95-1.03 
Diabetes   
  Type 1 3.05 0.72-12.91 
  Type 2 1.12 0.63-2.02 
C-reactive protein (high >3 mg/L vs. low <3 mg/L)  1.10 0.76-1.58 
*Controlled for age, sex, education and physical load factors 
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 5.2 UPPER EXTREMITY PROJECT (STUDIES II, III AND 
IV) 
The mean age of the patient population (N = 163) was 45 years, and 14% 
were men. Eleven percent were current smokers, 19% consumed alcohol 
twice or more often per week and 51% exercised 3 times or more per week. 
Fourteen percent were obese (BMI ≥ 30 kg/m2) and 25% were abdominally 
obese (waist circumference ≥102 cm in men and ≥88 cm in women).  
   Ten percent of the patients had high LDL cholesterol (>4.1 mmol/l), 4% low HDL 
cholesterol (<1.0 mmol/l) and 15% had high triglyceride levels (>1.7 mmol/l). Half 
(52%) of the patients reported having used painkillers for their upper extremity 
problem, most of them irregularly; 6% were receiving statin medication. The mean 
upper extremity pain intensity was 48 and the highest tertile cut-point of pain was 60 
(study 2). Thirty six percent of the patients had a shoulder disorder, 31% 
epicondylitis, 13% experienced a wrist disorder and 20% had non-specific 
upper extremity pain. Overall, 27.5% reported full or substantial recovery 
after 8 weeks and 32% after 12 weeks of follow-up (study 4). 
 
5.2.1 UPPER EXTREMITY PAIN (STUDY II) 
In age- and sex-adjusted models, waist circumference, levels of HDL 
cholesterol and triglycerides, the concentration of the adipokine visfatin, 
alcohol consumption and job strain were associated with upper extremity 
pain. Waist circumference (OR = 2.9, 95% CI 1.1-7.3 for obesity), a low level 
of HDL cholesterol (OR = 3.9, 95% CI 1.4-10.1), a high level of triglycerides 
(OR = 2.6, 95% CI 1.0-6.8) and a high level of the adipokine, visfatin (OR = 
1.4, 95% CI 1.0-2.1) were associated with upper extremity pain after 
adjustment for age, sex, alcohol consumption, job strain, depressive 
symptoms and regular statin medication use. The association between low 
HDL cholesterol and upper extremity pain did not change after further 
adjustment for waist circumference (OR 3.2, 95% CI 1.1-9.0). However, the 
association between high triglycerides and upper extremity pain did not 
remain statistically significant after further adjustment for waist 
circumference (OR = 2.3, 95% CI 0.8-6.8). Interestingly, the visfatin 
concentration was associated with upper extremity pain in both overweight 
and non-overweight subjects. 
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5.2.2 UPPER EXTREMITY SOFT TISSUE DISORDERS (STUDY III) 
The patients had a higher mean BMI (25.5 ± 4.4 vs. 23.1 ± 2.9 kg/m2, P 
<0.001), and a higher mean waist circumference (83.9 ± 12.7 vs. 80.0 ± 9.5 
cm, P <0.044) than the controls. Moreover, sleep disturbance was more 
prevalent among the patients than controls (31% vs. 13%, P = 0.016). The 
groups did not differ with respect to smoking, alcohol consumption or 
leisure-time physical activity. 
   Serum levels of sIL-1RII and sST2 cytokines were significantly higher in the 
patients with UESTDs than in the controls after adjustment for age, sex, 
smoking, body mass index, physical activity, alcohol consumption, and sleep 
disturbance. Moreover, the serum level of IL-18 cytokine was significantly 
lower in the patients compared with the controls. The associations of sIL-
1RII and sST2 with UESTDs were independent of BMI. Patients with low 
BMI (≤24.5 kg/m2) as well as those with high BMI (>24.5) had higher levels 
of sIL-1RII than the controls. 
 
5.2.3 RECOVERY FROM UPPER EXTREMITY SOFT TISSUE 
DISORDERS (STUDY IV) 
A high resistin level at baseline predicted a higher recovery rate from 
UESTDs during 8 weeks’ follow-up (OR = 1.53, 95% CI 1.15-2.04 for 1-SD 
increase) after adjustment for age, sex and follow-up time. In a stratified 
analysis taking into account overweight or obesity, high resistin level (OR = 
1.66, 95% CI 1.21-2.29 for 1-SD increase) and high visfatin level (OR = 1.91, 
95% CI 1-18-3-10 for 1-SD increase) at baseline predicted a better recovery 
rate from UESTDs in normal weight subjects (BMI <25 kg/m2) after 
controlling for age, sex and follow-up time. The associations between 
adipokine concentrations and recovery were non-significant in overweight or 
obese subjects. Moreover, high levels of resistin (OR = 1.52, 95% CI 1.08-2.11 
for 1-SD increase) and visfatin (OR = 1.47, 95% CI 1.03-2.08 for 1-SD 
increase) at baseline predicted a better recovery rate from tendon disorders 
after controlling for age, sex, follow-up time and BMI. In contrast, the 
associations between adipokine levels and recovery from non-specific upper 
limb pain were non-significant. 
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 6 DISCUSSION 
 6.1 MAIN FINDINGS  
The findings of this study indicate that the prevalence of shoulder joint pain 
in the past month was 16% whereas that of possible or probable chronic 
rotator cuff tendinitis was 3% in a representative sample of the general 
population. In patients with incipient conditions, every third reported full or 
substantial recovery from UESTDs within three months.  
   We studied several metabolic factors but only obesity and type 2 diabetes 
were associated with the prevalence of shoulder joint pain. Moreover, obesity 
was associated with chronic rotator cuff tendinitis. Serum interleukin 1 
family receptor sIL-1RII and sST2 and the pro-inflammatory cytokine, IL-18, 
levels were associated with UESTDs in the study among patients with 
incipient disorders and their age and sex matched controls. In patients with 
incipient UESTDs, lower levels of HDL cholesterol, and higher levels of 
triglycerides and adipokines were associated with greater intensity of upper 
limb pain. Moreover, adipokine levels predicted recovery from UESTDs.   
 
 6.2 PREVALENCE AND RECOVERY RATE 
The prevalence estimate for shoulder pain found in this study falls within the 
range of 12% to 30% in the past month which has been reported in previous 
studies (Luime, Koes et al. 2004, Miranda, Viikari-Juntura et al. 2005, Cole, 
Gill et al. 2009). The prevalence of rotator cuff tendinitis was about half of 
that previously reported (Walker-Bone, Palmer et al. 2004, Roquelaure, Ha 
et al. 2009). One reason for this discrepancy may be that we included only 
those cases with symptoms lasting more than three months.  
   Our recovery rate of UESTDs is comparable to the values reported in other 
populations. In a clinical trial of exercise programs among patients with 
supraspinatus tendinopathy, 15% of cases reported recovery after one month 
of follow-up and 40% after three months  (Şenbursa, Baltaci et al. 2011). A 
systematic review has found that half of new incident shoulder disorder 
episodes recover within 6 months (Kuijpers, van der Windt et al. 2004). A 
study investigating the prognosis of shoulder tendinopathy in employees 
doing repetitive work estimated that after 10 months about every second 
individual had no longer symptoms (Bonde, Mikkelsen et al. 2003). A study 
into lateral epicondylitis found that 37% reported no or minimal elbow pain 
after 2 months of physiotherapy and 38% reported no elbow pain after 6 
months of successive physical therapy or alternative treatments such as 
  51 
massage or pain killers (Waugh, Jaglal et al. 2004). In general practice, 
about every third (34%) of incident elbow complaints have shown full or 
substantial recovery after three months (Bot, van der Waal et al. 2005).  
   Overall, the findings of the current and previous studies indicate that 
UESTDs are relatively persistent conditions. Moreover, repeated exposure to 
physical load factors and an adverse metabolic environment may affect the 
healing process.  
 
 6.3 OVERWEIGHT AND OBESITY 
With respect to the investigated metabolic factors, both general and 
abdominal obesity were associated with shoulder joint pain and chronic 
rotator cuff tendinitis. According to one review, obesity is associated with 
tendon disorders in the shoulder, elbow and wrist (Gaida, Ashe et al. 2009). 
However, the case studies included in that review controlled for a limited 
number of confounders, which may have resulted in some overestimation of 
the actual associations. Many longitudinal studies have not found any 
association between BMI and shoulder pain (Lamy, Descatha et al. 2014, 
Kooijman, Barten et al. 2015). Obesity may, however, increase the risk of 
shoulder pain in individuals with hypermobile joints (Tobias, Deere et al. 
2013). With only one possible exception, previous studies on rotator cuff 
disorders or other UESTDs have not included assessments of abdominal 
obesity (Shiri, Viikari-Juntura et al. 2006). 
   There is no consensus on the pathways connecting obesity to UESTDs but 
two hypotheses have been presented to explain the possible mechanisms of 
upper extremity tendinopathy, one suggesting tendon damage caused by 
higher physical loads due to increased arm mass and the other implicating 
processes linked with the systemic inflammation triggered by adiposity 
(Abate, Schiavone et al. 2013, Franceschi, Papalia et al. 2014). Obesity 
increases the expression of several circulating biomarkers such as CRP and 
cytokines, e.g. IL-1 and TNFα that have been associated with shoulder pain 
and soft-tissue disorders of the shoulder. The obesity-induced increase in the 
levels of circulating pro-inflammatory cytokines may increase pain sensitivity 
and maintain inflammation in the rotator cuff.    
   A large waist circumference is an indicator of visceral fat mass, which is a 
metabolic risk factor known to increase susceptibility to diabetes and 
atherosclerosis. Visceral fat is the major trigger of systemic pro-
inflammatory biomarker expression and low-grade inflammation. Therefore, 
abdominal obesity as such may be a better metabolic risk marker than BMI 
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in future studies investigating the links between metabolic factors and 
UESTDs.   
 
 6.4 DIABETES 
In the current study, type 2 diabetes was related to shoulder pain, but not 
rotator cuff tendinitis. Moreover, we found a non-significant association 
between type 1 diabetes and chronic rotator cuff tendinitis. There is one 
meta-analysis which found evidence of an increased risk of tendinopathy 
among subjects with diabetes (Ranger, Wong et al. 2015). Furthermore, 
diabetes has been shown to be associated with chronic rotator cuff tendinitis, 
rotator cuff tendon tears, frozen shoulder, finger flexor tenosynovitis 
(Viikari-Juntura, Shiri et al. 2008, Abate, Schiavone et al. 2013) and a variety 
of other musculoskeletal complaints (Molsted, Tribler et al. 2012).  
   In agreement with our findings, some studies have reported an association 
of diabetes with shoulder pain and disorders (Mäkelä, Heliövaara et al. 1999, 
Roquelaure, Ha et al. 2009, Molsted, Tribler et al. 2012, Titchener, White et 
al. 2014, Lin, Lin et al. 2015). However, the associations of diabetes with 
distal tendon disorders have not been investigated in studies with large 
populations.  Diabetes was not associated with wrist tendinopathy in a 
prospective study among a working population (Harris, Eisen et al. 2011).  
   In patients with diabetes, advanced glycation end products (AGEs) are 
precipitated in the tendons of the rotator cuff. AGE accumulation causes 
tendon thickening and activates catabolic cytokines leading to tendon matrix 
degeneration, a possible factor predisposing to shoulder pain in individuals 
with type 2 diabetes (Abate, Schiavone et al. 2013).  
 
 6.5 DYSLIPIDEMIA 
In patients with incipient UESTDs, HDL cholesterol and triglyceride levels 
were associated with upper limb pain intensity. This relationship between 
lipids and upper limb pain is a novel finding although there are two previous 
studies that reported an association between HDL cholesterol and spinal 
pain (Schell, Theorell et al. 2008, Heuch, Heuch et al. 2010).  
   The role of lipids in UESTDs is unclear. Tendon health may be affected by 
the cholesterol level (Tilley, Cook et al. 2015). Cross-sectional studies on the 
association between serum lipids and rotator cuff tendon tears have shown 
inconsistent results (Scott, Zwerver et al. 2014). Moreover, a population-
based cross-sectional study did not find an association between serum lipids 
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and epicondylitis (Shiri, Viikari-Juntura et al. 2006). In contrast, two cohort 
studies reported an association between dyslipidemia and rotator cuff 
disorders (Djerbi, Chammas et al. 2015, Lin, Lin et al. 2015).  
   HDL cholesterol is an antiatherogenic particle attenuating inflammation 
and as such may be associated with pain (Lowenstein and Cameron 2010). 
Moreover, triglycerides may serve as a systemic innate immunity stress 
signal that activates pain perception (Hotamisligil 2006, Martinon 2008).   
 
 
 6.6 INFLAMMATORY BIOMARKERS 
In the current study, serum interleukin 1 family receptor sIL-1RII and sST2 
and pro-inflammatory cytokine IL-18 levels were associated with UESTDs. 
These findings may point towards IL-1 and IL-33 mediated inflammatory 
processes and down-regulation of IL-18 during the early stage of UESTDs. 
Serum levels of sIL-1RII and sST2 and IL-18 correlated positively with BMI 
in both patients and controls. Moreover, the associations between sIL-1RII 
and sST2 and IL-18 with UESTDs remained significant even after adjusting 
for BMI and other potential confounders as well as in stratified analysis by 
BMI, suggesting that these factors have independent roles in UESTDs.  
   We found increased levels of CRP in women with bilateral shoulder pain, 
suggesting that high circulating concentrations of this protein may be 
associated with higher susceptibility to bilateral shoulder pain. A systemic 
condition or a local process in the shoulders increasing circulating CRP could 
be possible mechanisms triggering bilateral shoulder pain. However, the CRP 
molecule per se may induce pro-inflammatory activity and therefore might 
be a potential independent factor modifying inflammatory processes in the 
shoulder (Verma, Li et al. 2002).  
   As far as we are aware, there are three studies in outpatient populations 
which have previously reported an association between serum biomarkers 
and upper extremity disorders (Carp, Barbe et al. 2007, Savitskaya, Izaguirre 
et al. 2011, Matute Wilander, Kåredal et al. 2014). However, these studies 
suffered from some methodological limitations that must be considered 
when assessing their conclusions. The study of Carp and colleagues, showing 
associations of CRP and TNFα with upper extremity disorder severity, was 
carried out in a small population of 22 patients and only nine controls. 
Moreover, after excluding patients with sprain or carpal tunnel syndrome 
from the analysis, only 12 cases of UESTDs were left in the analysis. The 
study of Savitskaya and colleagues, which detected a link between IL-1 and    
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IL-8 and degenerative rotator cuff tendinopathy, reported only the 
correlations between the serum biomarker levels and rotator cuff ultrasound 
findings. Furthermore, that study did not control the associations for known 
confounders such as age, sex and BMI. In the third study (Matute Wilander, 
Kåredal et al. 2014), increased levels of serum inflammatory markers were 
associated with pain in the neck and shoulder among 35 female cashiers but 
it did not report associations of the biomarkers with shoulder pain 
exclusively.  
   Previous studies in humans have suggested that there is elevated 
expression of IL-1 in the late stage of rotator cuff disorders (Gotoh, Hamada 
et al. 2001, Sakai, Fujita et al. 2001, Blaine, Kim et al. 2005, Voloshin, 
Gelinas et al. 2005) but the current study’s finding of these biomarkers in the 
early stage of UESTDs is novel. Therefore, increased soluble receptor IL1RII 
and ST2 transcription may occur in the early phase of UESTDs in an attempt 
to combat the actions of IL-1 and IL-33. The finding of a decline in IL-18 
levels, suggesting reduction of IL-18 transcription triggered in incipient 
UESTDs is also new and is opposite to the reports in patients with 
rheumatoid arthritis and osteoarthritis, who exhibit an increased expression 
of IL-18 (Shao, Feng et al. 2009). In addition, the activity of the IL-1 family 
cytokines may indicate the presence of innate immunity patterns in incipient 
UESTDs (Garlanda, Dinarello et al. 2013). 
 
 6.7 ADIPOKINES 
We found an association between the level of visfatin and upper limb pain in 
our cross-sectional study. In the longitudinal study, baseline levels of two 
adipokines, resistin and visfatin, predicted recovery from UESTDs up to 8 
weeks. First, the findings indicate that adipokines may modify upper 
extremity soft-tissue pain in incipient disorders. Second, adipokines may 
exert anti-inflammatory effects on UESTDs during the acute or subacute 
stage, generally considered to last from 6 to 12 weeks from the onset of 
symptoms, and we speculate that these adipokines may influence the 
recovery from UESTDs.  
   To date, no previous study has found evidence of a role for adipokines in 
UESTDs. Adipokines have been recognized in musculoskeletal disorders as 
mediators of joint inflammation (Lago, Dieguez et al. 2007); for example, 
both resistin and visfatin have been reported to participate in the 
pathogenesis of osteoarthritis and rheumatoid arthritis by modifying disease 
activity (Toussirot, Streit et al. 2007, Rho, Solus et al. 2009, Choe, Bae et al. 
2012, Duan, Hao et al. 2012). Visfatin promotes the pro-inflammatory 
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cytokine activity of IL-1 and IL-6, which are known mediators of joint 
inflammation (Lago, Dieguez et al. 2007). 
   In the current study, both resistin and visfatin were associated with 
recovery from UESTDs. Both adipokines are known to function 
bidirectionally i.e. in addition to their pro-inflammatory role, they evoke 
anti-inflammatory responses such as an increase in the level of TGFβ (Song, 
Lee et al. 2008, Son, Ahn et al. 2010, Kang, Kim et al. 2011), which has also 
been recognized in UESTDs (Bedi, Maak et al. 2012). TGFβ participates in 
healing and fibrogenic remodeling of tendon (Wang 2006). TGFβ may, 
therefore, be a potential cytokine that promotes recovery from UESTDs. 
Additionally, resistin has been found to participate in calcification processes 
(Burnett, Lee et al. 2005), and this could represent a link with the calcium 
deposits found in rotator-cuff tendinopathy. 
 
 6.8 STUDY STRENGTHS  
Health 2000 Survey 
The study population of the Health 2000 survey was representative and 
relatively large, which increased the reliability of the estimates of shoulder 
pain and rotator cuff tendinitis. In this respect, the findings can be 
generalized to the adult Finnish population. The examining nurses and 
physicians underwent a training course to ensure uniformity of the study 
protocol, which included structured interviews and clinical examinations of 
the participants. We investigated a wide set of metabolic risk factors such as 
several indicators of obesity and dyslipidemia.  
 
Upper extremity project 
Recruiting patients with incipient disorders allowed us to assess the early 
pathological processes involved in UESTDs. Moreover, this study was 
longitudinal and the response rates to the follow-up phone interviews were 
high.  Case definition of UESTDs was based on explicit diagnostic criteria 
and the final diagnosis was agreed between three specialists in physical and 
rehabilitation medicine and occupational health. We measured several types 
of cytokines and adipokines which are believed to display associations with 
musculoskeletal disorders.  
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 6.9 STUDY LIMITATIONS  
Health 2000 Survey 
A limitation of the Health 2000 Survey was cross-sectional design and 
therefore it does not allow causal inference. The chronological relationship 
between the exposures and shoulder pain or rotator cuff tendinopathy 
cannot be explored in studies with a cross-sectional design. Many of the 
studied lifestyle factors are long lasting in their nature. Although shoulder 
disorders may be also chronic in their nature, it seems reasonable to 
postulate that the studied lifestyle factors preceded rather than being a 
consequence of the onset of shoulder problems. 
   We did not assess sleeping posture habits. Unilateral shoulder pain can be 
provoked or exacerbated by lying on the painful side during sleep (Kempf 
and Kongsted 2012). Therefore, lack of controlling for sleeping posture 
exposure may have caused an overestimation of the role of metabolic factors 
in unilateral shoulder pain. 
 
Upper extremity project 
A limitation of this study was the small sample size and its female 
preponderance, which limited statistical power and generalizability. 
Furthermore, the control group was a selected sample. A larger random 
sample of the general population, at least of the same size as the patient 
population, would have been preferable. The control group was not matched 
by age and sex at the individual level. The control group was more likely to 
have higher income, higher educational background, lower BMI and smaller 
waist circumference and suffer from less sleep disturbances than the patient 
group. These differences may have resulted in an overestimation of the 
associations between the biomarkers and UESTDs.  
   We used different criteria to define the metabolic syndrome in the upper 
extremity project and the Health 2000 Survey, which may reduce the 
comparability of the findings with respect to the obtained associations. 
Moreover, we did not measure cytokines and adipokines in the follow-up 
assessment and were therefore not able to study the associations of changes 
in the levels of the cytokines with recovery from UESTDs.  
   We used self-reported outcomes for pain and recovery. Perceived 
musculoskeletal pain varies between individuals and is affected by 
psychosocial factors, and this self-reporting can possibly lead to some 
inconsistencies (Linton 2000). In this study, several individual factors (job 
strain, fear avoidance beliefs, depression) may have caused inconsistent self-
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reports of upper limb complaints, for which it was not possible to fully 
control.  
   Exposures to different work related factors were also based on individual 
self-reports that may have been modified by symptoms. For example, 
individuals living with pain may overestimate their physical load exposures 
(Viikari-Juntura, Rauas et al. 1996).  
 
 6.10 CONCLUSIONS 
At present, little is known about the role of inflammatory and metabolic 
factors in upper extremity musculoskeletal disorders. A notable proportion of 
studies on the role of inflammatory biomarkers in UESTDs have been based 
on rotator cuff tissue samples or in animal models of limb overuse. Only a 
few studies have explored the role of metabolic factors in upper extremity 
musculoskeletal disorders other than shoulder disorders. In the past years, 
however, the number of studies on the role of serum biomarkers in UESTDs 
has increased.  
   This study included several different types of metabolic factors and serum 
biomarkers; it revealed novel associations between them and shoulder pain 
and UESTDs. With respect to the metabolic factors, obesity and diabetes 
were associated with shoulder pain and rotator cuff tendinopathy. In 
addition, obesity and serum lipid levels were associated with pain in 
incipient UESTDs. With respect the studied biomarkers of inflammation, 
CRP was associated with shoulder pain, IL-1 family proteins were associated 
with incipient UESTDs and adipokines were associated with pain arising 
from UESTDs and with recovery from UESTDs. 
   The study findings suggest that metabolic risk factors such as obesity and 
diabetes may create an environment that can be harmful to upper extremity 
structures. Moreover, the findings suggest that serum inflammatory 
biomarker levels may be associated with shoulder pain and incipient 
UESTDs. Consequently, two mechanisms of altered serum inflammatory 
biomarkers levels in UESTDs may be proposed. First, serum biomarker 
levels may be modified in association with a condition that has secondary 
effects causing damage to the upper extremity tissues. Second, serum 
biomarker alterations may be a sequela of a local pathological process in the 
soft-tissues of the upper extremities.  
   Furthermore, the study findings suggest that adipokines may be involved in 
UESTDs in both their early (i.e. acute) and advanced (i.e. subacute) stages by 
modifying pain or recovery. 
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   However, the fundamental mechanisms linking the metabolic and 
inflammatory factors with the UESTDs remain unknown. Nonetheless, our 
results imply that studies on serum biomarkers might be useful for assessing 
inflammatory factors in UESTDs, being complementary to tissue sample 
studies. 
   The relationships of metabolic and inflammatory factors with UESTDs 
need further investigation. Future longitudinal studies should recruit larger 
samples, preferably a representative sample of the general population. 
Moreover, future studies should investigate diverse and new metabolic 
factors and biomarkers that also could function as mediators in the link 
between metabolic factors and UESTDs.  
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